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A B S T R A C T   
Aniridia, a rare congenital disease, is often characterized by a progressive, pronounced limbal insufficiency and 
ocular surface pathology termed aniridia-associated keratopathy (AAK). Due to the characteristics of AAK and its 
bilateral nature, clinical management is challenging and complicated by the multiple coexisting ocular and 
systemic morbidities in aniridia. Although it is primarily assumed that AAK originates from a congenital limbal 
stem cell deficiency, in recent years AAK and its pathogenesis has been questioned in the light of new evidence 
and a refined understanding of ocular development and the biology of limbal stem cells (LSCs) and their niche. 
Here, by consolidating and comparing the latest clinical and preclinical evidence, we discuss key unanswered 
questions regarding ocular developmental aspects crucial to AAK. We also highlight hypotheses on the potential 
role of LSCs and the ocular surface microenvironment in AAK. The insights thus gained lead to a greater 
appreciation for the role of developmental and cellular processes in the emergence of AAK. They also highlight 
areas for future research to enable a deeper understanding of aniridia, and thereby the potential to develop new 
treatments for this rare but blinding ocular surface disease.   
1. Introduction 
Aniridia is a rare, pan-ocular, bilateral and congenital disease 
affecting the normal development and function of almost all eye struc-
tures. Aniridia is inherited in an autosomal dominant manner, with high 
penetrance and yet with variable phenotypic expressivity even within 
the same family. A variable degree of iris hypoplasia or total absence of 
iris is the hallmark of the disease. Over 90% of cases of aniridia involve 
haploinsufficiency of the PAX6 gene, commonly due to heterozygous 
non-sense mutations on one copy of the gene. Well over 500 PAX6 
* Corresponding author. Dr. Rolf. M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland University, Homburg, Saar, Germany. 
** Corresponding author. Centre de Recherche des Cordeliers, INSERM U1138, Team 17. 
*** Corresponding author. Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. 
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unique mutations have been identified in patients with familial or spo-
radic aniridia (http://LOVD.nl/PAX6) occurring in all exons and in non- 
coding regions of the gene. They include point mutations leading to 
amino acid substitution, deletions, insertions, premature termination, 
splicing defects or loss of the entire gene. Aniridia can occur either as an 
isolated malformation or as part of a syndrome such as WAGR (also 
known as WAGR complex, Wilms tumour-aniridia syndrome, aniridia- 
Wilms tumour syndrome) caused by large deletions that affect both 
PAX6 and the adjacent WT1 gene. WAGR is characterized by Wilms 
tumour, Aniridia, Genitourinary anomalies and developmental delay 
(formerly ‘mental Retardation’) [1,2]. Aniridia may also occur in Gil-
lespie syndrome, caused by mutation in a different gene, ITPR1, con-
sisting of aniridia, cerebellar ataxia and intellectual impairment [3]. 
Although nearly all PAX6-aniridia patients develop progressive opaci-
fication of the cornea termed aniridia-associated-keratopathy (AAK), 
glaucoma and cataract, the underlying molecular mechanisms and 
physiological causes of the many pathological features of the disease 
have not yet been elucidated. A main reason for this is that ocular 
development, maintenance and regeneration involve crosstalk between 
different tissues, and complex interactions with the immune, nervous, 
and metabolic systems. 
AAK, also sometimes termed aniridia-related keratopathy (ARK) or 
aniridic keratopathy, is a highly prevalent condition in PAX6- 
heterozygotes that is potentially painful and severely limits functional 
vision [4]. As the cornea is readily accessible and can be partly or fully 
replaced, AAK is a prime target for therapies to improve vision in 
aniridia. Even a small reduction in the severity of AAK can translate into 
significant benefits in vision and ocular surface symptoms. Moreover, 
AAK is progressive, so it is worthwhile to concentrate efforts into un-
derstanding its pathogenesis and pathophysiology, because the potential 
may exist for slowing, altering, or even arresting its progression in 
younger subjects. 
Symptoms of AAK include breakdown of the corneal surface, with 
epithelial thinning or loss, inflammation with immune cell infiltration, 
vascularization and chronic progressive opactification. These symptoms 
overlap partly or wholly with those that arise when the stem cells at the 
periphery of the cornea – limbal stem cells (LSCs) – are deficient due to 
disease or injury. Traditionally, it has been widely believed that AAK is a 
consequence of a progressive limbal stem cell deficiency (LSCD) [5,6], 
although to date, there is no definitive proof of loss or degradation of 
limbal stem cells (LSCs) or their niche as the causal event triggering 
AAK. Given the complexity of the pathology present in AAK [7], it is 
more likely that PAX6 controls multiple physiological and biological 
factors that act together, and that their dysregulation in aniridia leads to 
AAK development. 
Identifying the possible underlying pathogenic mechanisms leading 
to AAK development and progression holds the potential for establishing 
new therapeutic options for the single greatest unmet need of patients 
severely affected by aniridia. In this review, we highlight key questions 
of importance – many still unresolved – concerning developmental as-
pects and the emergence of AAK. We show that to regard AAK as purely a 
limbal stem cell deficiency is to ignore the multiple developmental and 
pathogenic events in aniridic eyes, affecting multiple tissues, that may 
contribute to the onset or progression of the disease. We highlight some 
potential therapeutic strategies that may arise from a fuller under-
standing of the developmental basis of AAK. The topics discussed are 
also relevant more generally to diverse types of environmental or 
congenital corneal pathologies that involve LSCD, corneal neo-
vascularization and opacification. Finally, we present recent findings on 
translation of results from animal models to humans as a critical step in 
developing future therapies to treat AAK and understanding their rele-
vance to other corneal diseases. 
2. Are developmental deficiencies involved in the emergence of 
AAK? 
PAX61 codes for a key transcription factor that is essential for eye 
development and maintenance. PAX6 is expressed at the earliest stages 
of eye development and in multiple eye tissues throughout life. Several 
Pax6-heterozygous mutant murine strains (collectively ‘small eye’ or 
‘Sey’ mice) have been characterized and used as in vivo models of 
aniridia, to study the roles of the gene and the developmental and 
pathological aspects of the disorder [8]. The mouse models represent a 
spectrum of mutations. Some such as the Harwell allele Pax6Sey− H and 
‘Dickies small eye’ Pax6Sey− Dey are large deletions affecting Pax6 and 
surrounding genes, and show severe phenotypes that are perhaps not 
ideal for studying human aniridia and AAK [9–12]. Others, including 
Pax6Sey (=Pax6SeyMH), Pax6Sey− Neu (=Pax6Sey− Neu1), Pax6ADD4802, 
Pax6Coop, Pax6Aey11, Pax6AEY18 and the allelic series Pax62Neu to 
Pax610Neu and Pax6Leca1–4 include point mutations leading to prema-
ture termination, frameshifts or splice defects [9,13–16]. There are also 
engineered deletions (Pax6LacZ) and floxed alleles (Pax6flox) that yield 
large deletions upon action of Cre recombinase [17–19]. With the 
exception of some hypomorph alleles (Pax64Neu, Pax67Neu and Pax6Coop) 
and a gain of function (Pax6ADD4802), most alleles listed above are 
thought or known on the basis of nonsense-mediated RNA decay, phe-
notypes, and/or allelic complementation studies, to be null for Pax6. 
Unless stated otherwise, all Pax6 mouse mutants discussed below 
represent null alleles. 
Pax6-knockout results in early failure in lens placode development 
and anophthalmia (eye absence) but heterozygotes display a phenotype 
that resembles human aniridia, including a progressive AAK [14,28]. 
Although the phenotype of Pax6 mouse mutants is affected by genetic 
background and there is individual variation in severity even within 
litters, overall they are remarkably consistent models of AAK. Concor-
dance with human aniridia, however, is not complete. For example, 
Pax6+/− mice exhibit microphthalmia with a 10% reduction in eye 
diameter and reduced lens size; while microphthalmia can also occur in 
human aniridia, most patients have a relatively normal eye and lens size 
[20]. The extent to which microphthalmia in mice may modulate the 
anterior segment dysgenesis associated with Pax6 is not known, but it 
should be noted that the transgenic ‘PAX77’ mouse that overexpresses 
5–6 copies of human PAX6 exhibits microphthalmia (including micro-
cornea) without an AAK phenotype [21,22]. 
Typically, the Pax6 heterozygous newborn mice exhibit morpho-
logical alterations in the corneal epithelium. Separation of the lens from 
the cornea during development is delayed in Pax6-mutant mice and 
iridocorneal and/or lens-cornea adhesions similar to Peters’ anomaly 
may be observed at birth, dependent on mouse strain and the Pax6 allele 
[23–26]. The gross abnormalities these mice can exhibit at birth are 
small eyes and/or an opacity of the central cornea due to delayed or 
failed detachment of the lens from the cornea. In contrast to the murine 
models, the ocular surface of the majority of aniridia patients does not 
exhibit any apparent gross abnormality at birth. Exceptionally, rare 
cases of Peters anomaly are caused by PAX6 mutations [27] but in nearly 
all cases of congenital aniridia, a proper separation of the cornea and 
lens is observed [28]. Despite a seemingly normal cornea observed early 
in life, however, closer inspection of the central cornea in a 4-year-old 
children with congenital aniridia indicated reduced sensitivity to me-
chanical touch, reduced sub-basal nerve density and elevated presence 
of antigen-presenting dendritic cells [29]. Moreover, the corneal thick-
ness is known to be pathologically increased in aniridia, even in child-
hood [29]. As outlined below, PAX6 is expressed in many eye structures 
during development (section 2.1). Therefore, it is probable that AAK is 
1 Human nomenclature is used whenever applicable. If findings are species- 
related the gene/protein nomenclature of the species is used according to the 
literature source. 
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at least partly influenced by developmental defects and not solely due to 
postnatal emergence of pathological corneal function. AAK penetrance 
is full, but its phenotypic expressivity is highly variable between in-
dividuals, even between siblings [30]. This suggests that strong envi-
ronmental and stochastic components, and/or modifier genes that act in 
concert with PAX6 and vary between individuals can influence the 
expression of the disease. This could also be true for epigenetic differ-
ences between individuals that may modulate AAK severity. It would 
moreover be important to understand how the different eye structures 
influence each other during corneal development, and the role of PAX6 
levels in influencing the onset and severity of AAK. 
PAX6/Pax6, the mammalian orthologue of the Eyeless gene (Ey) in 
Drosophila, is a paired and homeodomain transcription factor which is 
essential for eye development. The activity of PAX6 in eye development 
is evolutionarily conserved as the human or mouse Pax6 genes can 
induce ectopic formation of the compound eye from Drosophila imag-
inal discs as well as in Xenopus embryos [31,32]. PAX6, however is also 
important for brain, gut and pancreas development [33–35]; see review 
[36]. This multiple organ involvement partially explains why hap-
loinsufficiency of PAX6 causes in adults, not only aniridia phenotype, 
but also several non-ocular conditions such as obesity, glucose intoler-
ance and diabetes, and anosmia [37,38]. Sleep disorders are also re-
ported in patients and PAX6 may impact brain structures such as the 
pineal gland [39]. 
The importance of PAX6 for different structures of the eye is high-
lighted by the fact that aniridia patients suffer from multiple eye ab-
normalities in both anterior and posterior segments of the eye. PAX6 is 
expressed in the multiple ocular cell types from the earliest stages of eye 
development and throughout life (Figs. 1-3). The exact role of PAX6 in 
lens and optic cup derivatives has been systematically investigated using 
conditional mutagenesis (reviewed in Ref. [40]). By contrast, the impact 
of Pax6 on corneal development continues to be further explored, 
requiring efficient genetic deletion in the various corneal cell types [41]. 
2.1. How is the anterior segment of the eye formed? 
In vertebrate eye development, Pax6 expression is detected in the 
anterior neural plate in the eye field region [42] and subsequently in 
both the neuroectoderm and surface ectoderm progenitors of the eye 
[18,33,42,43]. The surface ectoderm gives rise to the lens and corneal 
epithelial layers (lens, limbus and corneal epithelium), while the neu-
roectoderm populates the optic vesicles that undergo morphogenesis to 
form the optic cups. The outer layer of the optic cups is populated by the 
retinal pigmented epithelium progenitors (RPE), while the inner layers 
of the optic cup differentiate to form all of the retinal neurons and the 
Müller glia cells. The anterior optic cup rim gives rise to the iris and 
ciliary body pigmented epithelia Fig. 1). The ocular mesenchyme sur-
rounding the optic cup rim eventually contributes to the iris and corneal 
stroma. The high and continuous expression of Pax6 in cells that derive 
from surface ectoderm and optic cup (lens, corneal epithelium, iris and 
ciliary epithelium) is required for the expression of genes encoding 
transcription factors, structural and signaling molecules, which are 
critical for the morphogenesis and differentiation of the neuronal, pig-
mented and the transparent cornea and lens eye lineages. The role of 
Fig. 1. Eye development and PAX6 expression in the mouse. The green box shows the developing murine eye at different stages. The color code marks the embryonic 
origin of these tissues. (Blue: surface ectodermal, Green: Neural ectodermal; Grey: Neural crest; Yellow: Mesodermal). The yellow Box below shows the relative PAX6 
expression in these different structures. The neural ectoderm forms the optic cup as a double-layered structure and is important for lens placode development of the 
surface ectoderm. The distal tips of the optic cup will develop iris structures, and this coincides with very high PAX6 expression levels. The inner layer of the optic cup 
will form the neural retina the outer layer develops to retinal pigment epithelium. Upon separation of lens and surface ectoderm several waves of neural crest and 
mesodermal cells migrate into the anterior segment contributing to the corneal stroma, corneal endothelium, iris stroma and anterior chamber. Most of the data 
displayed derive from studies on murine development [19,33,43]. *Note that endothelium and stroma differentiation is displayed for mouse where endothelium and 
stroma differentiate from the same cell mass migrated in a first wave. However, it is unknown if endothelial cells are already specified prior migration [111]. A 
second migration wave later appears in the angle between future cornea and optic cup and differentiate into stroma of iris and ciliary body [47]. In human and birds 
three migration waves are observed. First endothelium is specified then mesenchyme migrates between epithelium and endothelium to differentiate to stroma and 
the third wave contributes to iris and ciliary body [46]. Graphics adapted from different sources [44,47,112]. 
L. Latta et al.                                                                                                                                                                                                                                    
The Ocular Surface 22 (2021) 245–266
248
Pax6 in each of these structures and the signaling cues that mediate their 
coordinated development during the formation of the anterior segment 
of the eye, as relevant to the onset of AAK, is briefly summarized in the 
next section. 
The anterior segment of the eye includes the cornea, conjunctiva 
anterior chamber, iris, lens and associated structures. In development of 
these structures, the neural and surface ectodermal cells interact with 
mesenchymal cells of neural crest and mesodermal origin. These various 
and complex interactions are briefly described below. For a detailed 
description of the associated processes, see reviews [44–47]. The puta-
tive influence of PAX6 dosage on these different processes in develop-
ment of the corneal phenotype is discussed in separate sections. 
2.1.1. Early development – surface ectoderm and optic vesicle 
Morphologically, the development of the eye is evident with the 
formation of the optic vesicles. 
The optic vesicles are PAX6-expressing bilateral evaginations from 
the diencephalon that give rise to the optic cup through morphogenesis 
(reviewed in Refs. [48,49]). The optic cup interacts with surface ecto-
derm, lens and migrating mesenchymal cells. Disruption of develop-
mental processes has been described by manipulating signaling 
pathways. A saucer-shaped optic cup, ventral coloboma, or a deficiency 
of periocular mesenchyme were observed by manipulating either Wnt-, 
Lrp6-, or retinoic acid signaling [50]. The peripheral rim of the optic cup 
contain progenitors that will give rise, during post natal stages to the 
pigmented and non-pigmented layers of the iris and ciliary body 
(reviewed in Ref. [51]). Wnt ligands and BMP signaling from the surface 
ectoderm elicit Wnt/GSK3β-response in retinal pigment epithelium 
progenitors (RPE) and are crucial for production of the correct number 
of RPE cells and proper curvature of the optic cup [50,52]. 
2.1.2. Lens 
As soon as the optic vesicle forms, in mice at E8.5, Pax6 is expressed 
in neuronal and surface ectoderm progenitors of the eye (See E8.5 
Fig. 1). The lens derives from Pax6-expressing lens-competent facial 
ectoderm which is contacted by the optic vesicle [53]. 
After the lens placode has been induced, it invaginates to form the 
lens vesicle. The detailed mechanisms of lens induction and genetic and 
signaling networks are reviewed in Ref. [54]. In the lens and optic cup, 
Pax6 expression is specified independently, by cis-regulatory elements 
[40,54]. Pax6 autoregulates its own expression and the Pax6 surface 
ectodermal enhancer element driving PAX6 autoregulation interacts 
with another transcription factor, SOX2 [55]. Sox2 expression is induced 
in the surface ectoderm upon an inductive signal from the optic vesicle 
and determines lens placode formation (See E9.5 Fig. 1) [56]. 
The cells from the anterior pole of the lens vesicle give rise to the lens 
epithelial cells, whereas the posterior cells differentiate into lens fiber 
cells. PAX6 continues to be expressed during lens invagination and 
Fig. 2. Aligned developmental stages of critical events in anterior eye development in several species. 
* Embryonic days or weeks of gestation (WG). A1,2,3). Earliest expression of PAX6 in surface ectoderm and neuroectoderm is further observed and sustained in 
several emerging structures such as optic vesicle, optic cup developing lens and surface epithelium [33,43,113,114]. Note that given time points for each species 
showed the earliest observed expression in the cited studies. B) Neural crest migration is important for contributing to corneal structures such as endothelium and 
stroma as well as iris stroma. In mice two migration waves are observed and in avian and human there are three reported waves, although there are inconsistencies in 
the literature [44–47,111]. B1) In mice neural crest cells increase at E13 [115]. In a second wave, mesenchymal cells migrate and contribute to stroma of the iris 
(E15.5) [47]. B2) In humans the first wave is in the 7th WG as no endothelial cells can be observed before [116]. In birds, the stroma is built up by mesenchymal cells 
migrating between epithelium and endothelium around the 8th WG [117]. Although there are descriptions of anterior chamber angle development, note that the 
migration path of these mesenchymal cells has not been addressed in those studies [118,119]. B3) In chicken there are three waves of NCC. The first wave leads to 
formation of the endothelium [120]; the second wave develops into corneal keratocytes [120] and the third wave of NCC contributes to iris and mesodermal cells 
become distinguishable from endothelium at the seventh day [121]. C) The timing of limbus formation, specification and maturation at the molecular level is still 
enigmatic C1) Before keratin surface markers become distinguishable (See D), expression changes could lead to lineage segregation of corneal and conjunctival cells. 
In the rat, CX43 expression is lost at E12 and could explain a spatial separation of limbus and cornea epithelium [74]. C2) In the human, single cell analysis identified 
clusters of corneal, conjunctival and limbal cell lineages [70]. KRT15 starts to become restricted to limbal epithelium five weeks later at WG17 in humans [71]. At a 
similar timepoint, single cell analysis also identifies different stem cell and progenitor markers [70]. C3) In the chicken, a diffusion barrier is established in the limbal 
region before cell lines can be distinguished by cytokeratin expression changes. Interestingly, the limbal barrier is established prior to expression changes in CX43 
[73]. D1,2) As apparent in the timeline, the changes in surface expression of keratins or integrins become clearer with further stratification. These processes occur 
much later than the first evidence of lineage segregation of conjunctiva, limbal and corneal epithelium (See Section 2.1.3). (Time points depicted in the graphics are 
obtained from cited literature. Stages are aligned with Carnie Stage comparison). Gestation Week (WG), E (Embryonic), P (Postnatal) [308]. 
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differentiation [19,57] as reviewed by Cvekl A et al. [58] and is main-
tained in the lens epithelium throughout life. 
2.1.3. Corneal stroma and endothelium 
After the lens, optic cup and ocular surface ectoderm have been 
specified, neural crest cells and mesodermal cells migrate between these 
structures. The corneal stroma is formed by neural crest-derived cells 
from the periocular mesenchyme, a population of mesenchymal cells 
located near the optic cup and presumptive lens. Fate mapping of 
mesoderm-derived cells showed a contribution to the corneal endothe-
lium and stroma [59,60]. 
In humans (and birds), three waves of neural crest cells (NCCs) 
migration are reported in contrast to two waves in mice (Note that Fig. 1 
refers to mouse development). A first wave of NCCs migrate between the 
lens and the surface ectoderm to form the corneal endothelium. A sec-
ond wave forms the stromal keratocytes. The third wave of NCCs con-
tributes to the ciliary body and iris structures (see Section 2.1.4). In mice 
a single wave of neural crest migration gives rise to both endothelium 
and stroma. 
Studies isolating primary stromal cells from transgenic mouse cor-
neas revealed similarities in mRNA expression profiles (Twist, snail, Slug 
and Sox9) between neural crest-derived precursors and the isolated 
corneal precursor cells. This finding was regarded as evidence for a 
neural crest origin of these cells, which are important for the turnover of 
stromal tissue [61]. 
The corneal endothelium provides an important pump function, 
actively maintaining a fluid and electrolyte balance between the ante-
rior chamber and corneal stroma to prevent corneal swelling, thus 
maintaining corneal transparency. The cellular density of this single 
endothelial cell layer is critical for maintaining an adequate pump 
function. From a histologic analysis of human fetuses, it has been shown 
that the cellularity of the endothelium rapidly decreases in the prenatal 
period from 16 weeks of gestation to term, at the same time the cornea 
grows in size [62]. The reduction in endothelial cell density during this 
period is about 50%, while the density reduces further by a third during 
the first two years of life. A putative effect of PAX6 levels on stromal, 
limbal stromal and endothelial development and how this could influ-
ence AAK is discussed in Section 2.6. 
2.1.4. Iris and anterior chamber angle 
The anterior chamber angle is the angle between the iris and the 
corneal endothelium in the limbal region. The iridocorneal angle con-
tains important aqueous humor drainage structures such as the trabec-
ular meshwork and Schlemm’s canal. 
The contiguous iris and ciliary body epithelia derive from the rim of 
the optic cup while the stromal layers derive from the ocular mesen-
chyme [26]. A Pax6 expression gradient is observed in the optic cup with 
the highest level from the distal (close to the lens) to proximal side (close 
to the optic nerve [33] (Fig. 1, E 15.5). 
For the iridocorneal angle, lineage tracing experiments in mice 
revealed the contribution of NCCs to the ciliary muscles, ciliary blood 
vessels, anterior iris, trabecular meshwork and Schlemm’s canal in the 
iridocorneal angle [59,63,64]. Mesodermal cells also contribute to 
structures such as the lining of Schlemm’s canal and the iris stroma, but 
not to the ciliary muscles [59]. Pax6 may participate in regulation of the 
factors required for the migration of NCC into the eye [65] (see also 
reviews on neural crest of the eye [44,66]). 
In mouse embryos (E 15.5), iris and ciliary body progenitor cells can 
be molecularly distinguished from cells which form the presumptive 
neural retina. Thus the proper development of the iris relies on the 
correct compartmentalization of the optic cup (See review in Ref. [26] 
for molecular details). 
Fig. 3. Postnatal PAX6 gene expression in humans. 
The green Box (A–D) shows the different eye structures in human tissue. The color code marks the embryonic origin of these tissues. (Blue: surface ectodermal; Green: 
Neural ectodermal; Grey: Neural crest; Yellow: Mesodermal). The yellow box below shows the same ocular tissues which exhibit sustained PAX6 expression during 
postnatal stages, thus likely also playing a role in adulthood. Note some Data from other model organisms are also transferred to the human structures shown here (E– 
H). There is evidence for Pax6 expression in lacrimal and meibomian glands based on expression arrays [122] (A, E). Pax6 is expressed in lens epithelium, ciliary 
body (B, F), limbal, corneal and conjunctival epithelium (C, G). In the adult retina, Pax6 is expressed in the ganglion cell layer and the amacrine cells of the inner 
region of inner nuclear layer (D, H). Graphics freely adopted from different Internet sources [306,307]. 
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Although the molecular mechanism responsible for the normal 
development of the iridocorneal angle has not yet been elucidated, a 
series of developmental steps are described in the mouse where final 
maturation of Schlemm’s canal and the trabecular meshwork extends 
postnatally to P42 [67]. In humans, the developmental processes are 
similar, with all rudimentary structures developed at birth [68]. Further 
maturation and reorganization take place, likely due to mechanical 
stress and aqueous humor flow and this process could last 1–8 years 
postnatally [69]. 
The impact of changing PAX6 levels on anterior chamber develop-
ment and possible impact on the ocular surface is discussed in Section 
2.5. 
2.1.5. Limbus and limbal stem cells 
After the lens has formed, the PAX6-positive cells of the surface 
ectoderm segregate and give rise to the lineages of the anterior ocular 
surface epithelia, including conjunctival and limbal/corneal lineages 
[19] (Fig. 1, E8.5-E15.5).). In humans (but not mice), specialized 
anatomical structures, the ‘palisades of Vogt’, develop at the limbus – 
the boundary ring around the periphery of the cornea where the stem 
cells reside in adult life. The developmental aspects of their formation is 
of utmost interest, as they are important for stem cell homeostasis and 
are affected in AAK. To make the overview easier to understand, a 
comparison of the key events of the anterior chamber development in 
different animal models is shown (Fig. 2). 
At 8.5 WG (week of gestation), the human fetal cornea is still 
continuous with the surface ectoderm. At 12–22 WG, in turn, individual 
components such as the conjunctiva, cornea and limbus can be distin-
guished by gene expression [70]. In 12 WG fetal corneas, the pre-
sumptive limbus is observed as ‘ridge like’ feature or a ‘dimpling’ in the 
epithelium [71,72]. In human fetal corneas, the palisades of Vogt are not 
yet detected and are probably formed postnatally. During 8–22 WG, the 
limbal epithelium starts to become thicker than in the surrounding 
cornea and conjunctiva. Single cell RNA-seq studies of the developing 
human cornea indicate the presence of a proliferating epithelial pro-
genitor cluster with highly expressed corneal epithelial stem and pro-
genitor markers TP63, CLDN1, CLDN4 and TXNIP at 18 WG, indicating 
the first presence of “a peripheral limbal-like region” harboring the 
limbal stem and/or progenitor cells [70]. 
Due to the lack of detailed molecular and mechanistic studies of cell 
fate determination in the mammalian limbus, corneal epithelium and 
conjunctiva, here we refer also to functional studies done in chickens, to 
elucidate the time points when the cornea and conjunctiva become 
spatially separated by a limbus. 
In the chickens, a diffusion barrier between the corneal epithelium 
and conjunctiva is established at embryonic day 8 (See Fig. 2 for species 
comparison) [73]. This observation is consistent with recent transcrip-
tional data from the developing human cornea at 12 WG, where there 
are two separate clusters of ocular surface and conjunctival epithelial 
cells [70]. This separation in chicken may be achieved through the 
differential expression of a connexin, CX43, or in response to other 
events allowing differential responses to, as yet unknown, inductive 
signals [73–75]. CX43 is present in the conjunctiva and is also strongly 
expressed in the corneal epithelium, but is absent at the limbal border 
region. This feature is thought to isolate limbal cells from signals in the 
surrounding tissues and to play a role in their maintenance in an un-
differentiated state [73]. The detailed signaling pathways underlying 
these processes, however, remain to be further elucidated. Interestingly, 
several markers of adult LSCs are initially expressed throughout the 
entire corneal epithelium and it is only after stratification that their 
labeling pattern becomes restricted to the limbal epithelium. In common 
with other adult stem cell systems, it thus appears that the adult stem 
cells are a spatially restricted subpopulation of a progenitor population 
that is specified during embryogenesis. Although the limbus is specified 
prenatally, there may be some overlap in stratification of corneal 
epithelium and further maturation of limbal structures. Thus, it could be 
hypothesized that signals from the stratifying corneal epithelium are 
also necessary for further maturation of the limbus (See Section 2.3), as 
could influence underlying corneal stromal cells (See Section 2.6). 
2.1.6. Specification of conjunctival-, corneal and limbal epithelia 
Despite their proximity within a contiguous ocular surface epithe-
lium and their common and persistent expression of Pax6 during 
development and throughout life, the corneal epithelial cells and the 
conjunctival epithelial cells belong to two distinct lineages [76,77] 
arising from different populations [78]. These two lineages arise 
simultaneously from Pax6 positive ectodermal cells that remain on the 
embryonic ectodermal surface of the developing eye once the lens 
vesicle has formed [79,80]. 
In vivo studies with ocular epithelial cells isolated from rabbits and 
transplanted into mice have shown that limbal and corneal epithelial 
cell-derived cysts contained only stratified squamous-type epithelial 
cells. In contrast, conjunctival epithelial cell-derived cysts contained 
stratified columnar-type epithelial cells interspersed with Periodic Acid 
Schiff (PAS) staining-positive cells with goblet-like structure [78]. 
Despite the fact that such isolated cells might not contain stem cells or 
may be influenced by differentiated co-transplanted cells, such findings 
would support the hypothesis that corneal and limbal epithelial cells 
originate from a different embryonic lineage than conjunctival epithelial 
cells, and that goblet cells originate from the conjunctival compartment 
and not following external modulation, as originally proposed [78]. 
Nevertheless, lineage tracing of these hypothesized progenitor pop-
ulations will be needed to unequivocally address this issue in wild type 
mice and furthermore, explore the ocular lineage specification in 
PAX6-mutated mice. 
In spite of their importance, relatively little is known about the 
factors regulating conjunctival goblet cell development. Conjunctival 
epithelial cells and goblet cells derive from a common bipotent pro-
genitor [81,82]. SAM Pointed Domain-Containing ETS Transcription 
Factor (SPDEF) has been described as a crucial transcription factor for 
goblet cell differentiation [83]. Goblet cell differentiation and mucin 
secretion appear to be directly related to the eyelid opening. In humans, 
the eyelids are fused until the 5th-6th month of intrauterine life, and 
goblet cells appear in the fornix extending toward the palpebral and 
bulbar regions from the 8th to 9th week of gestational age [84,85]. 
Studies are currently underway to evaluate when the neural regulation 
of goblet cell secretion becomes functional [86] and the hierarchical 
network of transcription factors regulating goblet cell development in 
healthy and pathophysiological conditions (reviewed in Ref. [87]). 
Some signals which prevent the conjunctival phenotype in the cen-
tral cornea epithelium are known [88,89]. The extent of PAX6 
involvement in these processes will be discussed further in Section 2.2. 
In contrast to the poorly known mechanisms determining cell fates, the 
tissue specific markers (mostly cytokeratins) for corneal limbal and 
conjunctival epithelia are well described, although species-specific dif-
ferences in some of these markers exist. 
The conjunctival, limbal and corneal epithelium are composed of one 
to two cell layers before eyelid opening, after which the thickness of 
these cell layers increases to 4–5 cell layers (see Fig. 2 for animal model 
comparison). Cells become stratified and distinguishable by their 
morphology, with basal cells having a cuboidal shape and being 
attached to the epithelial basement membrane. The intermediate wing 
cells (anterior to the basal cells) are present, and are in turn covered by 
flattened superficial squamous epithelial cells. In the fetus, only minor 
keratin expression is visible in the superficial shedding cells [72,90]. 
These processes are similar in different model organisms and have been 
previously summarized [91]. 
Early murine corneal epithelial differentiation takes place at em-
bryonic day 15 (E15), as expression of the Pax6-target gene Krt12 be-
comes apparent and is a specific marker of the corneal epithelium 
throughout life [92,93]. This is likely also true in humans, as the neutral 
counterpart of KRT12, KRT3, becomes visible in human fetal corneas 
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from 12 WG to 17 WG in superficial cells. By 20 WG, KRT3 can be 
detected in the superficial cells of limbus and cornea, similar to the adult 
cornea [71]. Notably, the sequential appearance of the KRT3 and KRT12 
pair is different in chicken and rabbit animal models [94]. 
In mice the developing limbus matures upon corneal epithelial 
stratification that is associated with eyelid opening around postnatal day 
10–14 (P10-14). KRT12 is expressed in the superficial epithelial cells 
and extends to all suprabasal cells and in later embryonic stages to all 
layers of the epithelium upon maturation [95,96]. The corneal epithe-
lium continues to mature up to 3–6 months postnatally [92]. Tran-
scriptional changes in the corneal epithelium upon eye opening in mice, 
which are similar to humans, have been summarized [91]. 
One week after birth, α9 integrin, which marks the limbal region in 
humans and in mice [97], is equally distributed across the entire corneal 
epithelium and becomes restricted to the limbus in mice and rats at 8 
weeks postnatally [90,98]. Similarly, keratins can be used to observe 
limbal maturation. KRT19 is found to be expressed throughout the entire 
murine corneal epithelium prior to eyelid opening, however after 
stratification, the expression of this keratin becomes restricted to the 
mouse limbal epithelium [99]. KRT19 is also reported to be concen-
trated in human limbal epithelium but species differences during 
maturation of corneal epithelium are likely [100]. 
In early human development (8–14 WG), KRT15 is expressed across 
the entire ocular surface including conjunctiva, limbal and corneal 
epithelia, but becomes restricted to the limbal epithelium from 17 WG, 
prior to eye opening (See Fig. 2 C2) [71]. 
These data seem to suggest that, before stratification of the ocular 
surface epithelium, stem cells are not restricted to the limbus but rather 
distributed throughout the entire limbal/corneal epithelium. (This 
would also point to the important role of stromal stem cell niche in 
maintaining stem cell capacity in adults as described in 3.1 Controversy 
on limbal stem cells). Additional support for this hypothesis came from 
the use of a X-chromosomal LacZ transgene, which allows random and 
irreversible labeling of embryonic blastocyst cells in female mice based 
on X-chromosome inactivation mosaicism at early embryonic blastocyst 
stage. Interestingly, in the first 3–4 weeks after birth, a disorganized 
mosaic pattern of LacZ+-labelled patches of cells appeared dispersed 
throughout the entire limbal/corneal epithelia. However, from P30 
onward, a typical radial stripe pattern of cell migration into the cornea 
became evident as the stem cells became restricted to the limbus [101]. 
These elegant studies [101,102] together with other studies mentioned 
above, indicate that the corneal epithelium is self-sustained by its own 
pool of stem cells, these stem cells probably differentiate before P30 and 
from that stage, the limbus becomes the unique stem cell location. 
Notably, the original ‘XLacZ’ mouse model has limitations due to the fact 
that tracing is of blastocyst-stage (E3-4) cells and because it does not 
allow cell type-specific tracing in a clonal, temporal manner by vital 
microscopy. However, advanced quantitative lineage tracing studies has 
further shown that this concept is correct, revealing additional aspects of 
limbal stem cell biology (discussed in section 3.1 below [103–108]). 
2.1.7. Corneal nerves 
In mice, branching nerve bundles cover the entire corneal stroma by 
E16.5. The corneal epithelium is first innervated at E16.5 and nerves 
subsequently form a swirl pattern in the subbasal nerve plexus at about 
three weeks postnatally [109]. The ophthalmic nerves arise from the 
trigeminal ganglion which is both derived from neural crest and ecto-
dermal cells (see the review in Ref. [45]. At least in chickens, the cornea 
is innervated solely by the neural crest derived neurons of the trigeminal 
ganglion [110]. 
2.2. Could disturbed segregation and separation of corneal and 
conjunctival cell lineages contribute to AAK? 
Lineage segregation of corneal epithelium from the conjunctiva in 
humans appears after sustained PAX6 induction at the time of surface 
ectoderm specification. In mice, PAX6 is found in the ocular surface 
ectoderm at E8, and in humans at embryonic day 42 (Fig. 2). Altered 
PAX6 levels in the corneal and conjunctival epithelium during devel-
opment could impact signals required to define borders and self- 
maintenance of corneal and conjunctival tissue identity. Deeper un-
derstanding of conjunctival and corneal differentiation is therefore 
essential to distinguish between the developmental and postnatal role of 
PAX6. In the mouse, the regulatory network of Pitx2 and downstream 
Dkk2 expressed in the mesenchyme inhibits Wnt/β-catenin signaling 
resulting in the inhibition of the conjunctival fate in the central cornea 
[88,89,123]. PITX2 is also described to integrate retinoic acid (RA) 
signaling from the surface ectoderm, optic cup and lens. Since RA 
signaling is altered in Pax6Sey/Sey (Pax6− /− ) mouse eyes [124], this 
could affect the crosstalk between the periocular mesenchyme and the 
surface ectoderm. In addition, transcriptional analysis in human subjects 
with aniridia indicates that RA metabolism could be altered in the 
conjunctival cells due to PAX6 mutation [125], but the mechanism re-
quires further confirmation. 
Whether PAX6 protein levels could impact proper segregation of 
corneal and conjunctival tissue during development, and therefore 
potentially influence the development of AAK, remains unknown; 
however, recent studies are beginning to address this question. A recent 
single-cell RNA-seq analysis of human corneal development [70] 
encompassing 12–23 weeks of gestation indicated low overall PAX6 
expression throughout the developing cornea; however, in all cases the 
highest expression was observed in the epithelial layer. The same was 
also true for the adult cornea with highest PAX6 expression observed in 
the corneal and conjunctival epithelium. Since several cell populations 
can be now identified by their transcriptional profile, it is now possible 
to investigate the extent to which PAX6 is expressed in these cell clusters 
or if some cells in these clusters exhibit higher or transient PAX6 
expression. Another recent study has reported postnatal modification of 
PAX6 dosage in the Pax6Sey− Neu/+ (Pax6+/− ) mouse model by inhibiting 
the mitogen-activated protein kinase (MEK) pathway [126]. In that 
study, pharmacologic MEK inhibition by ocular or systemic routes 
increased PAX6 protein expression in the basal epithelial layers to 
normal levels as in wild-type mice, resulting in restoration of corneal 
anatomy and transparency to a normal phenotype. This result provides 
evidence for a PAX6-dependent role in epithelial cell specification, even 
postnatally. 
2.3. Does the limbus of AAK patients exhibit developmental defects? 
Similarities between aniridia syndromes and LSCD may suggest that 
epithelial defects in AAK are the result of LSC failure. However, since 
pathological changes in aniridia are also observed in the nerves, in-
flammatory cells and corneal epithelium early in life, even before the 
limbus becomes overtly affected [29], it suggests that multiple patho-
logical mechanisms may be involved and may precede and/or promote 
LSC insufficiency. 
The exact location and differentiation characteristics of LSCs or their 
precursors during human development is not well studied at the mo-
lecular level, especially the postnatal formation of limbus niche struc-
tures which differ from those observed in mice [127]. It has been 
previously hypothesized that the delayed formation of the limbus could 
be a cause for the late onset of AAK in aniridia [71]. 
The ΔN isoform of Tp63α (ΔNp63α) is considered as a LSC marker 
[128] and as a master inducer needed for the progression from an em-
bryonic ectodermal monolayer epithelium into a dynamic, stratified 
epithelium found in the adult stage (e.g. in the corneal epithelium and 
epidermis) [129]. PAX6 expression occurs developmentally before the 
expression of TP63 [130,131]. In contrast to PAX6 that is widely 
expressed in eye tissues, TP63 expression is limited to the ocular surface 
epithelia (conjunctiva, limbus, cornea) and is associated with ocular 
glands (lacrimal and meibomian) [132,133]. Mutations in the TP63 
gene lead to Ectrodactyly-Ectodermal dysplasia-Cleft lip/palate (EEC) 
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and Ankyloblepharon-Ectodermal defects-Cleft lip/palate (AEC) syn-
dromes, two syndromes with numerous tissues affected. These syn-
dromes can also be associated with LSCD [134]. TP63 was described to 
be equally expressed in the fetal limbal and central cornea [71]. In adult 
humans, TP63 expression is restricted to the limbus, and positive 
staining is only detected in central corneal epithelium when the corneal 
epithelium is regenerating after wounding [71,135]. 
The occurrence of limbal stem cell dysgenesis shows that stem cells 
are required for corneal maintenance, however identifying the LSCs 
themselves is challenging [136]. Two recent single-cell RNA-seq studies 
led to the identification of glycoprotein hormone subunit alpha 2 
(GPHA2) as a novel marker of an outer population of limbal stem cells. 
GPHA2, is a largely unexplored gene whose function appears to be 
essential for LSC self-renewal and differentiation [70,107]. 
GPHA2-overexpressing transgenic animals showed no gross phenotype 
alterations [137], but it would be interesting to examine the phenotype 
of these mice and generate a knockout mouse strain. GPHA2 expression 
was dramatically reduced to barely detectable levels following cultiva-
tion of human LSCs and in immunodeficient mice. This suggests that 
GPHA2 may be regulated by T cells critical for the adaptive immune 
response, and that may serve as an important contributor to the LSC 
niche [70,107]. Noticeably, like the putative LSC marker KRT15, 
GPHA2 is not only expressed by basal limbal epithelial cells (i.e. LSCs), 
but it is also occasionally detected in limbal supra-basal cells [107], and 
therefore was also proposed to mark limbal committed or differentiated 
cells [138]. 
The processes, however, responsible for creating the limbal niche 
structure secretion of its basement membrane, as well as association and 
recruitment of niche cells, are not sufficiently understood. It would be of 
interest to determine whether GPHA2 expression is altered in AAK pa-
tients and/or in animal models of aniridia, to yield further evidence for 
the loss of LSC function, as is widely believed. In addition, lineage 
tracing in Pax6+/− mice enabled the detection of pathogenic mecha-
nisms associated with aniridia and the LSCs in light of developmental 
processes. For example, Pax6+/− LSCs in Pax6+/− ↔ Pax6+/+ chimeric 
mice are functional and produce streams of epithelial cells that migrate 
normally into the cornea, although these progeny are less likely to reach 
the center of the cornea than wild-type cells [139]. This suggests that 
dosage deficiency of Pax6 does not preclude normal specification of 
LSCs in a cell-autonomous manner. It remains unknown, however, if the 
relatively normal behavior of Pax6+/− cells in the chimeric mouse 
limbus represents a non-autonomous ‘rescue’ by secreted protein factors 
such as GPHA2 released from the wild-type cells. 
2.4. Does lens development impact AAK? 
In contrast to aniridia patients, Pax6Sey/+ (Pax6+/− ) mice have a 
more prominent anterior segment dysplasia and the lens often remains 
attached to the cornea. The mouse lens is larger in proportion to the rest 
of the eye, as compared to the human eye. This could result in a more 
severe lens and corneal phenotype in the mouse compared to the human 
eye [11]. In the chicken, it was shown that surgical removal of the lens 
affects multiple eye developmental processes including eye growth, and 
inhibits normal development of the peripheral retina, ciliary body, iris, 
and migration of NCC into the cornea [140]. The corneal cell fate of 
surface ectoderm is stabilized by NCC migrating in the lens peripheral 
ectoderm. The formed stroma prevents PAX6 downregulation in the 
corneal epithelium [141]. 
The developing lens is a key signaling center during eye develop-
ment. During formation of the lens placode, ligands of Wnt, BMP and 
retinoic acid secreted from the surface ectoderm play a role in patterning 
of the optic cup [50,52]. Surgical removal of the lens from developing 
chicken eyes leads to downregulation of genes associated with retinoic 
acid, BMP and Wnt signaling in the peripheral retina, including the 
ciliary body, and some aspects of the lens-deficient phenotype (e.g. 
microphthalmia) can be recapitulated by inhibiting retinoic acid 
signaling, or rescued in lens-removed eyes by restoring retinoic acid 
[142]. 
Pax6 is essential for early stages of lens induction, possibly through 
influencing modification and remodeling of chromatin [19,52] as 
reviewed in Ref. [54]. In addition to its role within the lens lineage, Pax6 
also plays a role in the adjacent optic vesicle to trigger lens formation. 
When Pax6 is knocked out at an early stage in the optic vesicle, the lens 
does not develop [113]. 
Consistent with the importance of Pax6 in lens formation, there is 
evidence that the lens is exquisitely sensitive to the correct Pax6 gene 
dosage. In Mexican Cavefish Astyanax mexicana, it is the loss of Pax6 
expression specifically during lens development, that precipitates lens 
apoptosis which in turn leads to failure of retinal growth and the loss of 
anterior segment structures [143]. In mice, less than 80% or more than 
120% of normal Pax6 activity is thought to result in lens defects that 
affect the rest of eye development, even though to adulthood [21]. 
Moreover, results from experimental inactivation one allele of Pax6 
in mice, specifically in the lens or in the optic cup, indicate that Pax6 
expression in the lens is necessary for normal development of the 
anterior chamber [112]. 
Further evidence of the sensitivity of lens development to Pax6 levels 
was concluded based on mouse chimera experiments indicating that 
heterozygous Pax6Sey− Neu/+ (Pax6− /+) cells do not contribute to the 
developing embryonic lens, in contrast to their contribution to the other 
eye tissues [144]. Additionally, in chimeric mice where the lens was 
wild-type, virtually all other aspects of anterior segment development 
were restored, including normal iris development, corneal epithelial 
morphology and limbal function [145,146]. 
A plausible working model for the developmental defects underlying 
the development of the aniridia phenotype is that lens signals regulated 
by the correct Pax6 dosage are required for normal development of other 
anterior segment structures. Identification of these lens signals orches-
trating anterior segment development should therefore be a high pri-
ority in eye research, irrespective of their roles in aniridia. 
An early onset of cataract is prevalent in aniridia [147]. This is likely 
due to abnormality of the lens epithelium and lens fiber cells, and a 
thinning of the lens capsule [148–150]. Non-cell-autonomous mecha-
nisms for cataract in aniridia have been also proposed as abnormal 
zonular fibers are reported to be associated with congenital cataract in 
aniridia [151,152]. 
Anterior opacities in the lens and iris remnants in the anterior 
chamber are sometimes observed in aniridic eyes (Fig. 4), suggesting 
that the separation of the lens and iris from the cornea may sometimes 
be arrested in human embryos [4]. Further detailed studies are neces-
sary to investigate if the lens status affects the corneal endothelium. 
Since the keratopathy is mostly present in the anterior layers of the 
cornea, it is not obvious whether an incomplete separation of the lens or 
iris from the cornea could impact AAK. The putative crosstalk between 
the lens and other developing ocular tissues has been discussed above. 
Similar to dysfunctional lens epithelial cells, an abnormally thin corneal 
epithelium in the heterozygous Pax6+/− mouse [28] may represent 
developmentally immature epithelial cells (including limbal stem and 
progenitor cells) incapable to form the fully stratified multiple corneal 
epithelial layers that normally arise postnatally in the mouse cornea 
[87]. However, it must be noted that any apparent undifferentiated state 
may be a secondary consequence of the chronic abrasion and 
wound-healing physiology of the aniridic cornea [153,154]. 
2.5. Does anterior chamber and iris malformation impact AAK 
development? 
The conditional inactivation of a single Pax6 allele in mice from 
either the inner layer or the outer pigmented epithelium of the distal 
optic cup results in a profound iris hypoplasia [51]. The resulting 
reduction in Pax6 dosage interrupts different stages of iris development: 
from reduction in the size of the progenitors, to delayed onset of 
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muscle-specific markers and abrogated iris sphincter morphogenesis 
[51,155]. Indeed several key factors for iris development are reduced in 
the developing iris of the Pax6Sey− 1Neu/+ mice including: Pitx2, Igf2, 
Foxc1, TGFb2, Zic2 and BMP4 [156]. These transcription factors and 
ligands could impact the differentiation of the iris progenitors as well as 
the migration of NCC that populate the iris stroma and the cornea [157]. 
The majority (50%–75%) of aniridia patients develop glaucoma most 
likely as a consequence of abnormal differentiation of the trabecular 
meshwork and/or complete absence of Schlemm’s canal [158,159]. 
Notably, conditional haploinsufficiency of Pax6 in the mouse lens and 
cornea - but not in the developing optic cup layers - disrupted trabecular 
meshwork and Schlemm’s canal development and resulted in glaucoma 
[145]. It is currently unclear, however, if this result is due to Pax6 ac-
tivity in the lens and cornea regulating factors required for the devel-
opment of the drainage structures, or due to the abnormal morphology 
of the eye due to adhesion between lens, cornea and iris epithelium in 
the model [145]. 
Another unsolved topic is how partial or complete loss of iris and the 
abnormal differentiation of the drainage structures in aniridia impact 
AAK progression. It should be considered that the positioning of the 
anterior chamber angle may be needed for signaling to LSC and their 
niche to develop correctly, as well as to ensure the proper flow of 
aqueous humor important to maintain the correct eye pressure and 
nutrition of the anterior segment structures. 
In a recent study examining 87 eyes of aniridia patients, 21 of which 
had a partial iris, it was shown that the partial presence of an iris was 
strongly associated with a milder degree of AAK [29]. Although this 
could support a connection between iris or chamber angle development 
and AAK, the mild keratopathy could also be caused by the common 
causative mutation itself. 
2.6. Are mesenchymal structures (corneal stroma and endothelium) 
affected during development? 
A number of clinical studies have reported that the corneal stroma is 
abnormally thick in almost all cases of aniridia [6,160,161]. Although 
the causes of a thick stroma in aniridia are not yet clarified (as the 
corneal endothelium appears to function normally), it has been reported 
that, during normal human development, the corneal stroma is thicker 
in utero and progressively thins with increasing gestational age [162]. 
This has led to the hypothesis that the normal thinning of the corneal 
stroma in later developmental stages in utero is disrupted in aniridia 
[29]. A developmental origin for the thickened corneal stroma is sup-
ported by the lack of clinical signs of stromal edema and a sufficiently 
high endothelial cell density in aniridia for maintaining proper stromal 
hydration. 
In the epithelia of the developing lens, retina, ciliary body, iris and 
cornea, PAX6 is expressed at high levels, and this is easily detectable by 
in situ hybridization, Western blot and immunohistochemistry. In the 
mesenchymal component of some other ocular tissues, such as the 
corneal endothelium, corneal stromal keratocytes and trabecular 
meshwork mesenchyme, low and transient levels of PAX6 (at the limits 
of detection by the above techniques) have been reproducibly demon-
strated during mid-late stages of development [163,164]. These low 
levels of PAX6 have nevertheless been shown experimentally to repre-
sent a cell-autonomous requirement for contribution of cells to the 
corneal endothelium and stroma, and also play a role in the differenti-
ation of trabecular meshwork [47,163,164]. Although PAX6 is down-
regulated in the trabecular meshwork of normal adult eyes upon 
differentiation [163], recent single cell analysis has revealed the pres-
ence of PAX6 transcripts in normal limbal corneal keratocytes, corneal 
stromal keratocytes as well as in corneal stromal stem cells, into adult-
hood [70]. This correlates with the previous observation of PAX6 
expression in a population of stromal stem cells [165]. At the single-cell 
level in humans, PAX6 mRNA is detected through all developmental 
stages at a low level [70]. (Fig. 5). 
Impaired development of the anterior chamber angle, iris and 
endothelium due to PAX6 haploinsufficiency has been carefully studied 
and reviewed in a number of reports [28,40,47,155,163], but the impact 
of PAX6-deficient corneal or limbal stromal cells on AAK remains elusive 
[166]. PAX6 dosage is self-evidently crucial for normal eye develop-
ment, so the molecular mechanism by which different tissues require 
either ‘high’ or ‘low’ levels of Pax6, and how dosage is controlled via 
regulatory DNA elements, still requires clarification. PAX6 directly in-
teracts with multiple other proteins [167,168] and the presence and 
stoichiometry of different binding partners in different cell types is ex-
pected to modulate PAX6 activity. Hundreds of genes are regulated, 
directly or indirectly, by PAX6 during eye development [169] and are 
affected to different degrees by changes in dosage. It is therefore ex-
pected that mesenchymal cells with ‘low’ levels of PAX6 will exhibit a 
different profile of downstream gene expression from epithelial cells 
with ‘high’ levels. The biological impact of PAX6-heterozygosity for low 
levels of expression in mesenchymal cells, if any, are unresolved. Taken 
together, the most parsimonious scenario is that PAX6, expressed at high 
levels, is functioning cell-autonomously in the optic cup, lens and 
corneal epithelium progenitors, and that these tissues have a 
non-autonomous influence on the surrounding anterior segmental neu-
ral crest and mesodermal lineages (See Fig. 5, blue arrows). As the 
Schlemm’s canal lining and iris stroma are formed by mesodermal cells 
[59] and are absent in Pax6+/− mice [65,170], it may be possible that 
transient PAX6 expression in these cells further contributes directly to 
their formation. 
2.7. Do meibomian and lacrimal gland formation impact AAK 
development? 
The functions of lacrimal and meibomian glands are essential for the 
production, stability and function of the tear film. Any factor disturbing 
the homeostasis of the ocular surface unit may disrupt the stability of the 
tears, leading to damage of corneal and conjunctival epithelia and 
possibly impacting LSC function [171]. These supportive glands are 
derived from the ocular surface ectoderm, but to date there is no evi-
dence regarding the impact of these structures on other anterior struc-
tures during eye development. The morphogenic events necessary for 
the lacrimal gland development in Pax6Sey/Sey mice are defective [172]. 
In Pax6Sey/+at E19.5, the lacrimal bud becomes visible but its structure 
remains vestigial [173]. In lacrimal gland organoid models, Pax6 is 
necessary for expression of the genes encoding the secretion machinery 
(aquaporins and neurotransmitters) but these analyses were performed 
with total Pax6 knockout model [174]. In addition, PAX6 is one of the 
transcription factors necessary to drive explant cultures or induced 
pluripotent stem cells (iPSCs) into a lacrimal gland cellular fate [173, 
175]. 
The development of the meibomian glands requires proper eyelid 
closure and eyelid fusion during embryonic development. PAX6 could 
influence this process since it is expressed at low levels during eyelid 
development in a complex expression pattern [176,177]. PAX6 is 
expressed during development in the acinar cells of meibomian glands, 
although its contribution to development of these glands requires 
further investigation [178]. Protein composition of the tear film is 
altered in aniridia, and an elevation in inflammatory cytokine levels has 
been observed [179]. Meibomian gland dysfunction has also been 
documented in aniridia patients [180–183]. Still, it is unknown whether 
tear film and meibomian gland abnormalities arise from developmental 
defects or whether the function is impaired postnatally due to deficient 
ocular surface epithelia. AAK may underpin the inflammatory process 
and act as a possible trigger mechanism for dry eye and meibomian 
gland dysfunction. Elevated interleukins in the tear film could be also 
caused by the chronic wound healing state of the corneal epithelium in 
aniridia or from inflammation in the limbus and corneal stroma [7]. It is 
also important to keep in mind that the developmental defects observed 
in mice may not necessarily be mirrored in humans. Longitudinally 
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monitoring the morphology and function of the meibomian and lacrimal 
glands and tear film quality from birth to young adulthood may help to 
answer these questions and could provide important insights for patient 
care. Interestingly, similar to PAX6-related aniridia, P63-mutation in 
patients that suffer from ectodermal dysplasia (ED) also led to meibo-
mian and lacrimal gland defects in addition to LSCD [134,184]. 
More precise information is needed about the spatiotemporal and 
functional importance of PAX6 expression in different tissues of the 
ocular surface during development and in adulthood, and critically, to 
determine the contribution of developmental abnormalities versus 
postnatal pathophysiological changes. Ongoing studies at the single-cell 
level in human corneas, supplemented with similar information in 
Pax6+/− mouse eyes, could provide the necessary platform for 
addressing these questions. In addition, identifying the gene regulatory 
networks and molecular pathways leading to normal PAX6 production 
could possibly provide a molecular tool to modify PAX6 levels [126], 
largely independent of the developmental stage and tissue type initially 
perturbed by PAX6 mutation. Armed with this information, it may be 
possible to identify potential drug candidates with the ability to delay or 
prevent the development of AAK postnatally. Crucially, the impact of 
any treatment should be evaluated in terms of lacrimal and meibomian 
gland function, to assess the likelihood of maintaining a stable ocular 
surface environment in longer term. 
3. How aniridia AAK symptoms manifest postnatally 
3.1. Is limbal stem cell deficiency a cause or a consequence of AAK? 
The limbus (meaning ‘border’ in latin) is the circumferential border 
defined by the corneoscleral transition and harbors the LSC niche. In 
humans, the niche is typically located in the superior and inferior limbal 
regions where the ‘Palisades of Vogt’ structures are found [185,186]. 
Accumulating evidence supports the hypothesis that the limbus is the 
sole niche of corneal epithelial stem cells, notwithstanding the impres-
sive regenerative ability of the corneal epithelial cells themselves [127]. 
The shape and structure of the limbus, rich with blood and lymph ves-
sels, suggests that it provides a protected microenvironment (LSC niche) 
that is enriched with nutrients and stem cell self-renewal factors 
[186–188]. Slow-cycling nucleotide label-retaining cells have been 
specifically identified in the limbus while in the corneal periphery and 
center, only fast-cycling cells have been identified [189]. Limbal 
epithelial cells have been shown to have high regenerative potential and 
long-term proliferation capacity in vitro and in vivo [190]. 
LSCs produce transient amplifying cells which undergo further di-
vision and centripetal movement to replenish the basal corneal epithe-
lium. A constant stream of these newly produced basal epithelial cells 
migrates towards the supra-basal epithelial layers and is accompanied 
by a loss of proliferation capacity leading to a terminally differentiated 
state [191]. Recent studies have identified two spatially discrete classes 
of stem cells in the limbus – an inner ring of active cells that are mostly 
responsible for repopulating the corneal surface during normal ho-
meostasis, and an outer, more quiescent ring that may have a role after 
injury [107,192]. It is this outer ring that expresses LSC marker GPHA2 
discussed earlier, while the inner ring is mostly responsible for the 
centripetal radial streams of corneal epithelial cells observed in mosaic 
reporter mice. 
LSCD is a group of diseases that can be caused by environmental or 
genetic factors and is accompanied by conjunctival cell invasion, 
inflammation, corneal neovascularization, corneal opacification and 
blindness [193]. It is commonly believed that dysfunction of LSCs and 
their stromal niche is the basis and cause for these pathologies [194]. 
Accordingly, the inability of LSCs to replenish the corneal epithelium 
leads to recurrent ocular surface defects and abnormal healing of the 
corneal epithelium, often being replaced by conjunctival cells [195]. 
This is often followed by neovascularization of the corneal stroma, 
compromised corneal transparency and consequently corneal 
opacification, leading progressively to poor vision. Typical changes in 
corneal epithelium-specific surface markers include the downregulation 
of corneal keratins KRT3/KRT12, and abnormal expression of conjunc-
tival keratins KRT4/KRT13 or skin keratins KRT1/KRT10 [196]. Also, 
goblet cells which are normally restricted to the conjunctiva, can be 
found in the cornea in cases of LSCD, and their presence has also been 
used to diagnose LSCD [195], although goblet cell presence can be 
variable in advanced stages of AAK [7]. Of note, PAX6 is also down-
regulated in severe ocular surface diseases including LSCD [196]. 
Controversy: Accumulating experimental and clinical evidence sup-
ported the LSC dogma, namely that the LSCs are located in the limbal 
niches and are solely responsible for epithelial renewal. This notion 
subsequently became firmly accepted by the research community. 
Nevertheless, there was some conflicting evidence that had been over-
looked or remains unresolved [197,198]. Perhaps one of the most 
confusing observations was reported in the seminal and elegant study of 
Tsengs’s group [199] which strengthens the importance of the limbus. In 
that study, the entire limbal epithelium in 12 New Zealand white rabbits 
was surgically removed. Six-months later, the cornea in 8 of the 12 
rabbits remained normal while the remaining four displayed only a mild 
phenotype of corneal neovascularization. However, when limbal 
epithelial depletion was coupled with epithelial debridement in the 
central cornea, corneas became vascularized. Likewise, in humans, a 
persistent central island of apparently normal corneal epithelium can 
persist for years, despite total limbal epithelial absence [198]. Similarly, 
Majo and Barrandon reported that the ablation of limbal epithelium in 
mice did not induce LSCD [127]. Limbal epithelial deletion is thus not 
necessarily sufficient to cause LSCD, however multiple lineage tracing 
studies in mice has shown the importance of LSCs in replenishing the 
corneal epithelium [103]. 
In a later experiment, Nasser and colleagues [106] showed that 
KRT15-GFP transgene specifically labels the limbal epithelium, and this 
model was used to validate limbal removal, ensuring total LSC deple-
tion. Using triple transgenic animals and multiple “Confetti” lineage 
tracing, one-day post total limbal epithelial depletion, the Confetti+
corneal epithelial cells healed the denuded limbus, and after 7-10 
additional days, these cells started to express limbal epithelial 
markers. These corneas were transparent, and the repaired limbus could 
successfully replenish the corneal epithelium for at least 6 months of 
experimental follow up. This study indicated that corneal 
epithelium-committed cells can dedifferentiate into apparent LSCs. 
When LSC depletion, however, is coupled with limbal stroma (niche) 
damage, dedifferentiation is inhibited and severe LSCD develops. 
Similar cell plasticity that allowed recovery from native stem cell loss 
has also been found in other epithelial tissues (reviewed in Ref. [200]). 
Collectively, these studies suggest that the LSC niche (and not the LSCs 
alone) is essential for maintenance of the transparent cornea, and that 
damage to the niche is most likely a key element of many LSCD pa-
thologies. In light of this, gene-linked LSCD (e.g., mutations in PAX6 or 
P63), are likely to affect both LSCs and their niche. This underscores the 
important role of the limbal niche in corneal health and LSCD patho-
genesis [201,202]. Nevertheless, the intriguing possibility remains that 
a signaling program triggering corneal epithelial cell dedifferentiation 
to LSC-like cells could be exogenously applied even in the absence of a 
functioning limbal niche. Investigations into the signaling pathways 
responsible for triggering and maintenance of the dedifferentiation of 
corneal epithelial cells would therefore be of interest. 
Aniridia-related LSCD: The limbal niche likely plays a pivotal role in 
the specific form of progressive LSCD observed in AAK. PAX6 is 
expressed in various tissues in adult eye (Fig. 3). PAX6 mutation may 
lead to aberrant crosstalk between mutated LSC and mutated stromal 
and epithelial elements (corneal stromal mesenchymal stem cells, ker-
atocytes, melanocytes, corneal nerves or dendritic cells). It may include 
an abnormal response to extracellular matrix (ECM) signals by mutated 
LSC, or dysregulated response of LSC to signals originating from blood or 
lymph cells. On the other hand, knockdown of Pax6 in cultured LSC 
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induces transdifferentiation into an epidermal-like fate [203], suggest-
ing that Pax6 could also play a cell-autonomous role in maintaining LSC 
identity. Clinical evidence also points to an abnormal limbal niche in 
aniridia, that is either the result of abnormal developmental processes in 
utero, or due to incomplete or aberrant postnatal development and/or 
maturation of the niche [204–207]. In young children and adults with 
aniridia, abnormal limbal structures, inflammation, vascularization and 
a significant nerve deficit in the limbus have been observed throughout 
the range of AAK severity [4,207]. These changes are also accompanied 
in an early stage by islands of conjunctival tissue present within an 
otherwise transparent corneal epithelium. The evidence therefore seems 
to indicate that an early breakdown in the limbal niche may prevent a 
proper limbal niche environment from forming. This would impact 
proper maturation of the limbal epithelium and the sustenance of its 
associated stem cells and/or progenitors. On the other hand, if the 
limbal niche in aniridia was fully functional but only the mutated LSCs 
were dysfunctional, corneal epithelial cells could presumably dediffer-
entiate and occupy the limbus as LSC-like cells. This is not in line with 
clinical observations, suggesting that PAX6 mutation could impair the 
dedifferentiation process. Still, the role of PAX6 in LSC differentiation 
and epithelial cell dedifferentiation remains to be elucidated. 
Comparison of AAK with other pathologies or genes causing ocular 
surface defects: 
Many cellular and tissue properties are altered in aniridia, leading to 
pathologic changes associated with stem cell and ocular surface insuf-
ficiency that are also apparent in other rare disease entities such as se-
vere dry eye, neurotrophic keratopathy and chronic inflammation. 
Several of these pathological processes are summarized in Fig. 6. Thus, a 
comparison of AAK to other eye diseases, which are not detectable at 
birth, but that could lead to stem cell deficiency could bring new in-
sights. Several ocular surface diseases are associated with down-
regulation of PAX6 in the corneal and conjunctival epithelia [196,208, 
209]. The limbus in aniridia may just be more sensitive to signals 
leading to pathology since the baseline level of the PAX6 protein is 
already low. LSCD can be induced by pathological triggers, such as 
chemical burns, infections, auto-immune disease [193]. The different 
signaling leading to epithelial-to-mesenchymal transition or fibrosis-like 
activation of transforming growth factor beta (TGF-β) by various cyto-
kines as alreay hypothesied by Tseng et al. are summarized by Ljubimov 
et al. [210]. Thus, mechanisms uncovered in the context of aniridia may 
have bearing on other etiologies, and vice versa. Mutations in genes 
coding for key transcription factors and in stem cell-related genes (e.g. 
TP63 [134], Klf4 [211,212], PITX2 [213], Sox2 [131]) exhibit LSCD-like 
phenotypes in transgenic mice. 
Interestingly, some of these transcription factors are also involved in 
neural crest and/or periocular mesenchyme specification. For example, 
Pitx2, a gene associated with anterior chamber dysgenesis if mutated, is 
mainly expressed in the developing corneal mesenchyme and later in the 
corneal stroma but not in surface ectoderm derived cells [88]. Inter-
estingly, PITX2 mutation is associated with an iris hypoplasia similar to 
‘classical’ aniridia [214]. 
An inflamed and stressed environment has been reported in the 
Pax6+/− mouse epithelium. Elevated oxidative stress has been suggested 
as one important mechanism in developing AAK [153,154]. Altered 
calcium waves lead to activation of ERK1/2 in mouse models [215]. It 
has been reported that Desmoglein-1 (DSG1) together with Erbin1 can 
Fig. 4. Right eye of a 10-year old female with 
aniridia and incomplete anterior chamber devel-
opment. (A) Optical coherence tomography image 
of the lens epithelial congenital anomaly resulting 
in a fibrous structure protruding into the anterior 
chamber (arrow), along with iris remnants (ar-
rowheads). (B) Slit lamp photograph illustrating 
the superficial lens opacity in the center as a result 
of congenital fibrous structure (arrow). ads). (B) 
Slit lamp photograph illustrating the superficial 
lens opacity in the center as a result of congenital 
fibrous structure (arrow).   
Fig. 5. Sustained and transient PAX6 expression in 
different ocular tissues Ectodermal-derived structures 
are indicated in blue and green color in the upper part 
of the figure. Their relative PAX6 expression is high, 
illustrated by intensity of the red color. The mesen-
chymal derived cells (grey and yellow color) exhibit 
only a low or transient PAX6 expression and 
contribute to corneal stroma, iris stroma, and ciliary 
body structures. PAX6 function may be cell autono-
mous in the stroma, differentiation of trabecular 
meshwork and in the corneal endothelium (green 
circles). PAX6 expression in ectodermal derived 
structures is high and continuous (green and blue 
colors in the left part of the central figure). This high 
expression is necessary for inductive events, for 
example for guidance of NCCs toward the cornea or 
anterior chamber angle (blue arrows) (See Review 
article Cvekl and Tamm [47] for further information). 
Note that the schematic images are based on both 
human structures (adult) and mice (development) and 
are mixed in this figure. PAX6 expression is super-
imposed to human eye structures in the two images on 
the right. (adapted from Cvekl A and Tamm [47]).   
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suppress ERK activation in epidermis [216]. Notably, DSG1 is down-
regulated in the epithelium of Pax6Sey/+ mice [24] and therefore, 
together with elevated calcium, an activation of the ERK1/2 pathway 
could negatively impact differentiation through altered signaling in 
addition to oxidative stress. In line with this, pharmacologic inhibition 
of ERK1/2 in human corneal limbal epithelial cells led to upregulation of 
PAX6 and increased the production of PAX6 protein [126]. 
Corneal-conjunctival boundary: Progressive infiltration of conjunc-
tival goblet cells into the limbus is believed to be due to LSCD, but this 
assumption should be carefully studied. For instance, KRT12-positive 
goblet cells could migrate into the cornea after large wounds [217]. 
Also, in two clinical studies, only about 30% of aniridia cases had goblet 
cells in the cornea [7,29] detectable by in vivo confocal microscopy. The 
use of goblet cells for diagnosis of conjunctivalization and LSCD may 
thus have drawbacks due to a heterogeneous distribution of goblet cells 
and potential presence of KRT12-positive goblet cells [217]. From ex-
periments analyzing both the limbus and conjunctiva, it is known that 
conjunctival cells share some stem cell markers with LSCs (e.g., KRT15, 
KRT19 and TP63) [218]. Thus, there is a lack of specific markers to 
distinguish conjunctival cells from corneal progenitors [98,218]. It 
makes difficult to prove or disprove the presence of conjunctival pro-
genitors in the limbus with existing markers; however, conjunctival cell 
migration patterns would differ as these cells are not typically mobile 
and conjunctival stem cells are enriched in the fornix region [219]. If, 
however, the corneal epithelium or limbus is defective, the behavior of 
conjunctival cells could change. Finally, it remains unanswered whether 
infiltration of conjunctival goblet cells into the corneal epithelium is a 
cause or a consequence of LSCD. 
PAX6 expression level and LSCD: In humans, PAX6 is expressed quite 
uniformly in both the limbal and corneal epithelial cells, regardless of 
the degree of differentiation [196]. Alteration of the PAX6 protein level 
has an impact on different aspects of corneal homeostasis (stem cell 
survival, stem cell renewal, adhesion, migration, proper differentiation) 
[23,24,28,139]. These properties were recently recapitulated in vitro in 
a PAX6-haploinsufficiency cellular model by genome editing of human 
limbal cells [220]. Other alterations in the limbus have been reported, 
for example that epithelial cell proliferation is slightly enhanced in 
Pax6+/− mice [23]. Hyperplasia in the limbus coupled to altered dif-
ferentiation could explain why the thinning of the corneal epithelium 
occurs before the onset of conjunctivalization in aniridia. Such 
morphological changes in aniridia are already detected at birth, 
although no apparent clinical consequences are observed at that early 
stage. It is likely that abnormal development, as discussed above, im-
pairs LSC function and/or the LSC niche from birth in congenital 
aniridia. 
Pax6+/− mice have limbal epithelial label-retaining (presumed) stem 
cells [221]. In aniridia-like Pax6Sey− Neu/+ mice, cell lineage tracing ex-
periments revealed epithelial cell migration out of the limbus into the 
cornea (although the pattern of radial migration across the cornea was 
abnormal) [139]. These lines of evidence, and the wide expression 
pattern of PAX6, suggests that Pax6+/− mice do in fact have functional 
stem cells. However, Pax6 haploinsufficiency may reduce the number of 
LSC, or affect their ability to self-renew, undergo asymmetric cell divi-
sion and/or diminish the potency of short-lived corneal epithelial pro-
genitors. Such disturbance of proliferative capacity has been also 
described in Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome, 
where the epithelium is also thin [222]. It is also currently not known 
whether the spatial distribution of outer, Gpha2-positive, quiescent LSCs 
and inner, Gpha2-negative LSCs described above for wild-type mice and 
humans is disrupted in Pax6-mutants. In chimeric mice (mixtures of 
wild-type and Pax6+/− cells formed by aggregation of eight-cell em-
bryos), the contribution of Pax6+/− cells to the limbus was slightly but 
significantly reduced compared to wild-type, suggesting a mild defi-
ciency of maintenance or proliferation of LSCs. However, relatively 
normal radial stripes of corneal epithelial cells emerged from the limbus 
to populate the cornea in these chimeras [139], Furthermore, corneal 
epithelial thickness and stratification was normal, suggesting that other 
tissues (lens, keratocytes or unaffected corneal epithelial cells) could 
rescue, by paracrine effects, the murine AAK phenotype [139]. Further 
work has provided additional evidence that the Pax6+/− cells 
Fig. 6. Molecular alterations responsible for AAK progression in animal models and humans. The image is a compilation of in vitro and in vivo data of how observed 
alterations in the biological processes could lead to AAK if disturbed. The bottom of each box refers to Sections in the text where these hypotheses are further 
discussed [309–312]. 
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themselves are unable to respond to guidance cues originating from the 
corneal stroma [223]. 
Corneal neovascularization: Neovascularization of the cornea is not a 
specific phenomenon of AAK but a consequence of LSCD and chronic 
inflammation and wound healing in general. When the ocular surface is 
inflamed, with high levels of inflammatory cytokines in tears and 
migration of inflammatory cells into the central cornea, new vessels 
sprout and migrate towards the central cornea along with conjunctival 
tissue. In advanced AAK a thick, opaque pannus forms that replaces the 
epithelium. How is the cornea normally maintained in an avascular 
state? Maintenance of an avascular transparent state has been attributed 
to a tightly regulated balance between pro- and anti-angiogenic factors 
in the corneal epithelium and stroma [224]. If the endogenous signaling 
networks preventing angiogenesis are impaired, a favorable environ-
ment for blood vessel growth will ensue. 
For example in the corneal epithelium, soluble vascular endothelial 
growth factor (VEGF) receptor-1 (sVEGFR-1 or sflt-1) is required to 
maintain corneal avascularity and its expression has been reported to be 
impaired in aniridia [225]. Restoring sflt-1 expression in the Pax6+/−
mouse cornea leads to regression of blood vessels [225]. The microRNAs 
miR-204-5p and miR-184 have also been shown to be expressed in the 
cornea [226–228], and are involved in both Pax6 signaling and regu-
lation of angiogenic signaling [229,230]. miR-204-5p is encoded by 
MIR204 that is located in intron 9 of the human TRPM3 gene on chro-
mosome 9 [231]. In animal models, Pax6 binds directly to 5’ regulatory 
sequences upstream of Trpm3 to upregulate both Trpm3 and Mir204 
transcripts [232–234]. miR-204-5p impacts lens and retinal develop-
ment [231,232], but is also strongly downregulated in conjunctiva cells 
in aniridia [125]. Moreover, a feedback loop exists whereby in the 
Japanese rice fish medaka, miR-204 represses the transcription factor 
Meis2, which in turn regulates Pax6 expression [235]. miR-184, also 
known for its roles in neovascularization and homeostasis in the cornea 
[236], was shown to be essential for Pax6 expression in embryonic stem 
cells that were differentiated into corneal epithelial-like cells [228]. It 
also repressed angiogenesis of cultivated LSCs by targeting proangio-
genic factors [228]. 
VEGF-C, another pro-angiogenic factor primarily involved in lym-
phangiogenesis, was found by proteomic analysis to be elevated in the 
tear film in aniridia, correlating with the presence of lymph vessels in 
the cornea in advanced-stage AAK [7,182]. Further pro-angiogenic cy-
tokines were later found to be elevated in the tear film in aniridia, 
including basic fibroblast growth factor (FGF-2) and interleukin-1β 
[179]. These and other pro-inflammatory cytokines, as well as inflam-
matory cell infiltration [7], represent an environment conducive to 
neovascularization. Interestingly, in a case report of long-term topical 
anti-VEGF treatment of corneal neovascularization secondary to anir-
idia, progression of AAK was seemingly halted and central vision was 
maintained during a 12-year period [237]. This raises the possibility of 
long-term treatment of the pro-inflammatory and pro-angiogenic 
corneal environment as a means to prevent, halt or potentially even 
reverse the progression of AAK. To investigate whether this could be a 
potential strategy for AAK management would require controlled 
studies, with participants carefully selected for mutational status, stage 
of AAK and rate of progression. 
3.2. What is known about the limbal niche? 
It is generally accepted that stem cells require a specific supportive 
environment to maintain in situ their undifferentiated state and prop-
erties of self-renewal and differentiation. As soon as daughter cells 
migrate into the peripheral or central cornea, local features of the limbal 
niche environment and the factors they provide are no longer present, 
eventually leading to (terminal) differentiation of epithelial cells. This 
raises essential questions concerning the niche location and its molec-
ular nature. Mesenchymal tissues are known to have a tight crosstalk 
with their neighboring epithelia and serve as a niche for epithelial stem 
cells, as has been shown for example with hair follicle bulge cells 
[238–240]. Corneal stromal stem cells support limbal stem cells in 
cultured feeder layer systems, and are similarly believed to be important 
in LSC maintenance [241]. Seminal grafting experiments show that the 
type of epithelium (epidermis versus corneal) is dictated by its under-
lying stroma [242]. Corneal epithelium that was exposed to embryonic 
dermal signals underwent transdifferentiation into hair follicle forming 
epidermis. Such a niche should be composed of the surrounding cells 
and the secreted ECM deposited by the different cell types. Surrounding 
the LSCs are mesenchymal (neural crest or mesodermal derived; see 
Fig. 2) cells (keratocytes), blood vessels, nerves, immune cells, mela-
nocytes, and stromal stem cells, all located in the peripheral stroma. It 
has been proposed that mesenchymal cells physically interact with LSC 
via SDF-1/CXCR4 signaling to maintain stem cell function [243]. This 
apparent link between LSC, the stromal niche and surrounding immune 
cells fits well with the presence of lymph/blood vessels around the 
limbus and the recent demonstration of lymphatic capillaries as critical 
SC-niche components in the skin [244]. 
In addition, the basement membrane composition of the limbus is 
different from the basement membrane of the central cornea [245,246]. 
The molecular composition of the niche-derived ECM has been identi-
fied with laser captured tissue by, showing that LSCs are attached to the 
basement membrane through laminin receptors, and intercellular con-
tacts between LSCs and their niche cells are mediated mainly by cad-
herins [247]. Binding between epithelial and stromal cells is mediated 
by N-cadherins [248], and mesenchymal cells and melanocytes have 
been suggested to support stem cell properties and to enhance the clonal 
growth of LSCs in vitro [249,250]. N-cadherins are also expressed in 
widely used 3T3-feeder cells and could be important for homogenic and 
heterogenic cell-to-cell binding with niche cells such as melanocytes 
[248,251]. In vitro, melanocytes have been suggested to support the 
stemness of limbal cells [252]. 
In contrast, however, to surface ectodermal or neuroectodermal- 
derived structures, the limbal niche cells show only low or even tran-
sient PAX6 expression, and the specific ablation of PAX6 gene in these 
cells has never been achieved. It is thus, difficult to identify the direct 
contribution of PAX6 to limbal niche function. Although PAX6 is typi-
cally not detected by stromal cells, it was reported that stromal cells in 
the limbus express ABCG2 and PAX6 [253], and the associated proteins 
encoded by these genes may support the limbal niche. It is not clear if 
PAX6 influences limbal melanocytes, but it is involved in the melano-
genesis of the retinal pigmented epithelium though activation of MITF 
[254]. Interestingly, MITF mRNA is downregulated in the aniridic 
conjunctiva [125] but it is not known whether the limbus in aniridia is 
melanocyte deficient. It was shown that limbal mesenchymal cells could 
substitute 3T3-feeder cell function in a 3D culture model system [255]. 
However, whether these positive effects are dependent on PAX6 
expression in mesenchymal cells has not yet been addressed, nor is it 
known whether the limbal stromal mesenchymal cells are present or 
functional in aniridia. 
From clinical studies, it is known that patients with aniridia show a 
degradation of the limbal niche structures coinciding with a progressive 
ocular surface transformation [6,7]. Thus, it is possible that the limbal 
niche structure and function could be maintained despite the clinical 
diagnosis and absence of iris in congenital aniridia, depending on the 
type of PAX6 mutation. However, as discussed above and in particular in 
the case of ‘classical’ PAX6-related aniridia, the limbal niche environ-
ment is perturbed in infancy and possibly from birth, leading to LSCD 
regardless of the early postnatal presence of the limbal niche. 
The mechanical properties of the niche are also important to protect 
the LSCs [256]. Altered mechanical properties could affect proliferation 
and differentiation of LSCs [257] and may therefore impact AAK if 
mechanical properties in the niche are altered. Gouveia et al. have 
shown that LSCs can be regulated by modulation of biomechanical 
factors and that a mechanically compliant limbal niche substrate sup-
ports LSC properties at least in part through regulation of Hippo 
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signaling. Migration of transient amplifying cells into the corneal 
epithelium from the limbus may in part be driven by durotaxis – driving 
cells from areas of high substrate compliance (the limbal stroma) to low 
substrate compliance (the corneal stroma) [256]. Moreover, increased 
stiffness at the limbus is present in LSCD and this may have important 
implications for our understanding of AAK, if it reduces the durotactic 
drive for cells to enter the corneal epithelium from the limbus [256]. If 
confirmed in patients, an appropriate strategy for manipulating stiffness 
of the limbal niche could potentially restore its pliability and conse-
quently its capacity to support LSC function as a novel therapy to pre-
vent or even arrest the development of AAK in the future. Of note, the 
fibrovascular pannus that is observed to invade the limbus as AAK 
progresses is a mechanically more rigid and tough tissue than the orig-
inal limbal epithelial and underlying stromal extracellular matrix tissue. 
3.3. Do stromal cells influence aniridia? 
In the normal adult corneal and limbal stroma, a very small pro-
portion of cells show a low level of PAX6 expression [165] but these may 
represent stromal stem cell populations generally related to keratocytes. 
Since corneal stromal cells can differentiate (at least in vitro) into cells 
with a keratocyte phenotype when cultivated as neurospheres, it is 
intriguing to speculate a role for PAX6 in early keratocyte differentiation 
which may be of relevance to corneal stromal changes occurring in 
aniridia [258]. Haploinsufficiency and overexpression of Pax6 both lead 
to alterations in the corneal stroma and endothelium in mice [259]. 
Pax6Sey− Neu/+ mice exhibit increased stromal cell apoptosis, abnormal 
wound-healing responses and reduced levels of MMP-9 secretion [260]. 
Studies are currently underway to characterize stromal cells isolated 
from aniridic patient corneal buttons at the time of corneal graft trans-
plantation surgery, which may shed light on the properties of 
PAX6-mutant stromal cells and their role in AAK. 
Co-culture of normal corneal and limbal stroma with limbal and 
corneal epithelial sheets showed that limbal stroma modulates epithelial 
cell differentiation and proliferation whereas the corneal stroma pro-
motes their differentiation [261]. Corneal stromal signaling is important 
for stratification of the epithelium and involves the WNT/β-catenin 
signaling pathway [262]. 
AAK coincides with major changes in signaling in the epithelium and 
derangement of the corneal stromal architecture, with a subepithelial 
pannus in the anterior stroma either lacking collagen I or only faintly 
labelled, but positive for collagen IV, fibronectin, tenascin-C, vimentin 
and α-SMA, in addition to displaying fibrotic markers and containing 
blood vessels [258,263]. The remaining posterior stroma appears to 
have an almost normal morphology, including expression of type I 
collagen. The changes in the stroma could be relatively nonspecific and 
not related to mutation of stromal cells since they are also induced in the 
stroma of healthy corneal donor tissue which consists of non-mutated 
stromal cells, but it is known that AAK recurs after standard corneal 
transplantation due to the LSCD. The corneal endothelium is also of 
mesenchymal origin (See section 2.6). In humans, no alteration of 
corneal endothelium has been observed in aniridic patients thus far 
[29]. Regular Descemet’s membrane and normal to slightly elevated 
endothelial cell counts are usually observed in patients with aniridia 
[29,264]. Cases with lower endothelial cell count have been found in 
older patients, but these are usually associated with morphological 
changes such as cornea guttata or with pleomorphism/polymegethism 
due to a long history of topical treatments for glaucoma or previous 
surgeries such as cataract extraction [265]. 
Notably, it has been shown that PAX6 could be secreted, as already 
reported for other homeodomain proteins [266]. This could suggest 
previously undetected nonautonomous effects for PAX6 in the cornea, 
and that PAX6 produced and secreted by epithelial cells could be 
internalized by the adjacent stromal cells. In this case, altered PAX6 
dosage could have an indirect effect on stromal homeostasis. In zebra-
fish, antibodies capturing secreted PAX6 lead to developmental defects 
[267]. In the future, it must be elucidated if such biological processes 
could be important not only for eye development in zebrafish, but also 
for corneal epithelial-stromal interactions. Experimental co-culture 
systems might be useful for addressing these questions. 
3.4. Is limbal cell identity altered in aniridia? 
In contrast to the spatially restricted LSCs, conjunctival stem cells 
can be found in all regions of the conjunctiva, but are predominantly 
located in the medial canthal and inferior forniceal areas [268]. Since 
lineage segregation of corneal epithelium and conjunctiva appears after 
PAX6 induction [33,80], some functional overlap for PAX6 function in 
corneal and conjunctiva should exist. The focus of PAX6 on corneal 
epithelial phenotype might be misleading since sustained PAX6 
expression is also present in the conjunctiva and other factors may drive 
tissue-specific expression downstream of PAX6. For example, studies 
link severe ocular surface disease such as Sjogren’s syndrome with a 
reduction of PAX6 expression in the conjunctiva [209]. Therefore, the 
question of the role of PAX6 in the conjunctiva and its contribution to 
AAK has been recently raised. Transcriptomic analysis of conjunctival 
cells was recently investigated in a cohort of 20 aniridia patients mostly 
showing AAK signs. Changes in gene expression and pathways related to 
proliferation and pro-angiogenic pathways (FOSB, FOS, JUN, ATF3, 
FOSL1, EGR1, NR4A3, IL8) suggested that conjunctiva is part of the 
pathology in aniridia where it is abnormally proangiogenic and prolif-
erative [125]. The molecular link between angiogenesis and PAX6, 
however, requires further investigation. The expression changes 
observed in patient-derived conjunctival cells could also result from 
secondary effects due to inflammation or severe dry eye. 
Of interest, the anti-angiogenic miRNA-204-5p mentioned above is 
under the control of PAX6, and its expression is strongly reduced in the 
conjunctiva of aniridia patients [125,234]. Notably, two of the subjects 
in the cohort had mutations in regulatory elements of PAX6 (located in 
the adjacent ELP4 gene) and these mutations are thought to lead to a 
milder PAX6 reduction compared to the haploinsufficiency caused by 
mutations in coding regions of PAX6. miR-204-5p expression was sup-
pressed to a lesser degree in these two subjects relative to those with 
PAX6 coding mutations, and this correlated with a very mild AAK 
phenotype [125]. Likewise, only mild deregulation of genes involved in 
retinoic pathway (RBP1, ADH7, ALDH3A1, CYB1B1, PPARG) was found 
in these two subjects, in contrast to the major mis-expression found in 
classical loss-of-function PAX6 mutations. In line with this, siRNA 
knockdown of PAX6 in primary limbal epithelial cells reduced ADH7 
and DSG1 expression [269]. 
Comparing published transcriptomic data between limbal and 
conjunctival epithelia from aniridia patients in vivo and cellular models 
in vitro, reveals a relatively minor overlap (unpublished data). This may 
reflect the absence of the niche from the in vitro context. Also, an 
important drawback is that much of the data described in the available 
literature was produced in a late stage disease. Given the complexity of 
the eye and the aniridia pathology, a blueprint of the transcriptome and 
proteome of different ocular epithelial cell types in vivo, including 
various differentiation states at early disease onset is desirable, to 
investigate how PAX6 influences the genetic programs of these different 
cell types. 
3.5. What is the role of inflammation in aniridia? 
Important inflammatory changes are observed in the cornea in 
aniridia. These have been documented in several patient cohorts and 
include an infiltration of mature antigen-presenting dendritic cells into 
the central cornea, infiltration of non-dendritic inflammatory cells, 
upregulation of inflammatory cytokines, and a deficit of corneal nerves 
[7,29,270]. The question arises as to whether these inflammatory 
changes precede or are a consequence of AAK. Clinical evidence sup-
ports the contention that inflammation precedes the development of 
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AAK based on inflammatory cell infiltration of the limbal epithelium and 
central cornea during the first few years of life while the limbus is still 
intact [29]. Because progression of AAK is associated with a chronic and 
worsening inflammatory status of the ocular surface [29], it is possible 
that early subclinical inflammation may trigger AAK. The inflammatory 
environment may then be reinforced in a vicious circle, through in-
flammatory signaling induced by degradation of corneal limbal struc-
tures, infiltration of inflammatory cells from the conjunctiva and from 
the circulation via invading blood vessels, lack of supportive neuro-
trophic factors (see Section 3.6), and the presence of inflammatory cy-
tokines in the tear film [7,179,182]. On the other hand, the 
inflammation observed early in life prior to degradation of the limbus, 
may itself be triggered by incomplete limbal developmental and post-
natal maturation processes. Features such as blood vessel sprouting from 
an incomplete cellular structure of the limbal palisades and the migra-
tion of dendritic cells from limbal and conjunctival regions into the 
central cornea [29] may indicate that the limbal niche in aniridia is 
insufficient to prevent inflammatory cells from entering the cornea. 
Ocular surface inflammation is always present in eyes with LSC 
deficiency, and presents a risk for stem cell transplantation, requiring 
therapeutic immunosuppression prior to limbal transplantation [271]. 
Mesenchymal cells have been shown to modulate the immune response 
in several systems, and may therefore also play a role in limbal niche and 
inflammatory signaling [272,273]. Interestingly, therapeutic mesen-
chymal cell transplantation in aniridia has shown promising early clin-
ical results [274], and may overcome the disadvantages of LSC 
transplantation in aniridia, possibly due to the enhanced immunomod-
ulatory properties of mesenchymal stem cells. Different types of lym-
phocytes such as T-cells [275] and dendritic cells [276,277], reside at 
the limbus and in the cornea. The antigen-presenting dendritic cells 
(also known as Langerhans’ cells) are normally resident in the limbal 
region and can be visualized using in vivo confocal microscopy [276]. In 
healthy individuals, mostly immature, non-antigen-presenting dendritic 
cells are present in the central cornea in the basal epithelial layers. In 
aniridia subjects, however, there is an increased presence of mature, 
antigen-presenting dendritic cells, even at a young age. A higher density 
of dendritic cells could be explained by a developmental delay, since the 
dendritic cell population reduces after birth in the central cornea [29]. 
Since the limbus may mature postnatally [71,278], a correct spatial 
isolation of antigen-presenting dendritic cells may not occur in aniridia, 
leading to persistent inflammation throughout the corneal epithelium. 
Elevated inflammatory cytokine levels have been observed in the 
tear film of aniridia patients, and this may be a causal or exacerbating 
factor in the chronic wound healing response observed in mice [154, 
179] and known to exist in human aniridia patients. Interleukins are 
expressed in healthy corneal epithelium and are released upon wound-
ing. Although it is unclear whether inflammation triggers the initial 
AAK, it is important to control the ocular surface inflammation in 
aniridia as it may slow down the progression and consequently improve 
the prognosis of AAK. Interestingly, it was shown that in tears taken 
from subjects with aniridia, there is not only an increase in the 
pro-inflammatory cytokine IL-1β, but its anti-inflammatory counterpart 
IL-1RA is diminished, suggesting an imbalance in cytokines can promote 
or sustain the inflammation observed in aniridia [183]. This is remi-
niscent of the altered pro/anti-angiogenic factor balance in the cornea in 
aniridia. 
3.6. Do corneal nerves play a role in AAK development? 
The cornea is the most densely innervated peripheral tissue in the 
human body. Most corneal nerve fibers are sensory in origin and are 
derived from the ophthalmic branch of the trigeminal nerve. Corneal 
nerves and corneal epithelial cells release modulatory substances and 
growth factors that provide trophic support to each other, to maintain a 
healthy ocular surface [279,280]. Local and systemic disease, however, 
can impair corneal innervation leading to decrease in tear production 
and impairment of wound healing [279]. Neurotrophic factors released 
by corneal nerves, often in the context of inflammation and wound 
healing, include nerve growth factor (NGF), epidermal growth factor 
(EGF), substance P (SP), calcitonin gene-related peptide (CGRP), 
acetylcholine, cholecystokinin, noradrenaline, serotonin, neuropeptide 
Y (NPY), brain-derived neurotrophic factor (BDNF), and neurotrophin- 
(NT-) 3 [281]. SP and CGRP modulate corneal epithelial cell prolifera-
tion, migration, adhesion, and stratification [279]. In addition, admin-
istration of SP combined with insulin-like growth factor-1 (IGF-1) can 
increase the corneal healing rate and promote corneal epithelial cell 
adhesion [282]. Conditions such as AAK, where ocular surface homeo-
stasis is disrupted, can upset the close and important interaction be-
tween the nerves and the epithelium, impairing the normal corneal 
renewal process and leading to inflammation and a wound healing state. 
A recent study by Lagali et al. reported a significant corneal nerve 
density deficit in PAX6 aniridia subjects (n = 46), that declined further 
with age. This was associated with significant corneal sensitivity 
reduction, reflecting a chronic impaired neurotrophic status [29]. The 
combination of limbal deficiency and reduced corneal sensation in 
subjects with PAX6 aniridia would have a significant impact on the 
maintenance of the ocular surface, contributing to the development of 
an unstable corneal epithelium often associated with AAK. Perturbation 
of the neurotrophic function may also impact inflammation of the ocular 
surface, which is widespread in aniridia. The cornea normally enjoys an 
immune-privileged status, which plays an important role in corneal 
immune response, particularly in promoting corneal allograft survival. 
Corneal immune privilege is dependent on the interplay of several 
important factors such as: (i) an absence of blood vessels (limiting direct 
access of the immune system to the cornea) and lymphatic vessels 
(preventing efferent movement/delivery of antigens and 
antigen-presenting cells (APC) to T cells located in the draining lymph 
nodes; (ii) a lack or low expression of major histocompatibility complex 
(MHC) class I and II antigens; (iii) presence of anti-inflammatory mol-
ecules, e.g., TGF-β, IL-10, IL-1RA; (iv) an Anterior Chamber-Associated 
Immune Deviation (ACAID) induced response, and finally (iv) pres-
ence of FasL, resulting in the apoptosis of infiltrating T cells. Many of 
these factors, however, are upset in AAK, leading to inflammatory cell 
invasion, expression of proinflammatory cytokines and a loss of immune 
privilege. Notably, different populations of immune cells have been re-
ported in the cornea of subjects with AAK [7] and the 
pro/anti-inflammatory cytokine balance is perturbed in the tear film in 
aniridia [179]. 
Dendritic cells (MHC Class II positive mature antigen presenting cells 
capable of antigen presentation to naïve T-cells) are one type of in-
flammatory cell normally resident in the corneal stroma and epithelium, 
with highest density in the periphery. As described above, dendritic cells 
play an important role in corneal homeostasis as sentinels of both innate 
and adaptive immunity. Resident corneal dendritic cells also have a role 
in maintaining homeostasis of corneal nerves [283], suggesting a direct 
interaction between the immune system and peripheral nerves at the 
ocular surface level. As indicated above, a significantly elevated density 
of mature dendritic cells exists in aniridia subjects when compared with 
normal individuals [29]. This emphasizes the close relationship of 
dendritic cells, inflammation and neurotrophic status of the cornea in 
PAX6 aniridia patients. Macrophages, normally occupying only the 
corneal stroma, reside in close proximity to peripheral nerves [284, 
285]. Macrophages express SP receptors, produce SP, and it is also 
known that neurotransmitters including SP can modulate immune ac-
tivity, although more investigation is needed to completely elucidate 
whether SP is affected in aniridia. It is known, however, that the 
decrease in corneal nerve density in AAK is associated with simulta-
neous invasion of inflammatory cells reflecting disease progression and 
corroborating the interaction between the nerves and immune system 
[286]. 
It is not clear whether problems with innervation are partly 
responsible for insufficiency of the limbal niche in aniridia. In normal 
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eyes, the basal side of the Palisades of Vogt is densely populated by 
corpuscular nerve endings, suggesting that neurotrophic factors may 
support stem cells not only directly, but indirectly by maintenance of the 
limbal niche [287,288]. Human corneal-limbal organoids appear to 
maintain good niche function without innervation in vitro [289], but 
this does not preclude an in vivo role in niche development or mainte-
nance. In mammals, though not in birds, PAX6 is expressed transiently 
during early development of the trigeminal ganglion, in cells of both the 
OpV and mmV-derived components, and this correlates with delayed 
innervation of sensory structures such as whisker follicles in mutants 
(unpublished data). Putative links between PAX6 mutation, disruption 
of limbal-corneal innervation, the degradation of palisade structure and 
[207,270] deficiency of the limbal niche require further investigation. 
As immune cell infiltration into the cornea facilitates (and is facili-
tated by) neovascularization, a deficit of corneal nerves may directly or 
indirectly play an important role in development of neovascularization 
in AAK. In experimental models of corneal neovascularization and tri-
geminal nerve ablation in the mouse, blood vessel invasion was shown 
to occur only in areas devoid of nerves, where inflammatory leukocytes 
and macrophage-lineage cells also infiltrated the cornea [290]. 
Conversely, where the nerve supply remained intact, the cornea 
remained vessel-free. A loss of antiangiogenic factors was noted in 
denervated corneas, in particular loss of vascular endothelial growth 
factor receptor-3 (VEGFR3) expression in the corneal epithelium and 
loss of pigment epithelium-derived factor (PEDF) expression in the 
corneal stroma. In a different mouse model of inflammation-induced dry 
eye disease, corneal nerves were diminished and expressed elevated 
levels of the proinflammatory neuropeptide SP [291]. Blockade of SP or 
its neurokinin-1 receptor effectively prevented vascular endothelial cell 
activation and reduced corneal neovascularization. In addition, VEGF 
has been shown to mediate corneal repair in abrasion-induced corneal 
nerve damage models, where VEGF blockade effectively suppressed 
nerve regeneration [292,293]. The source of VEGF in the corneal 
abrasion model is infiltrating T-cells and neutrophils [292]. Taken 
together, these studies indicate that corneal nerves, where damaged or 
accompanied by inflammation or when lost entirely, lose their ability to 
express angiostatic factors and instead express proinflammatory and 
regenerative factors, contributing to enhanced corneal neo-
vascularization. These effects can be considered part of the normal 
wound healing response, and may thus explain why the cornea in AAK, 
which is in a chronically inflamed wound-like state, is characterized by a 
deficit of nerves and an abundance of blood vessels. Potential thera-
peutic approaches supplying deficient factors such as VEGFR3 or PEDF, 
or blocking factors aiding neovascular growth such as SP or VEGF, 
warrant further investigation in relevant in vitro and in vivo aniridia 
models. 
Given the role of corneal nerves in maintaining avascularity and 
epithelial integrity, restoration of a healthy corneal nerve population 
may represent a viable therapeutic approach for AAK. As described 
above, autologous serum eye drops have been shown to relieve symp-
toms of neuropathic corneal pain and increase the abundance of corneal 
nerves in non-aniridia subjects [294]. In subjects with toxic corneal 
epitheliopathy induced by anti-glaucoma eye drops, a course of autol-
ogous serum drops significantly improved corneal sensitivity [295]. In a 
cohort of thirteen subjects with AAK, autologous serum eye drops 
instilled over an 8-week period resulted in subjective improvement in 
keratopathy symptoms and healed corneal epithelial defects in several 
cases; however, neovascularization and stromal scarring did not signif-
icantly improve during the course of treatment [296]. Longer-term 
treatment, careful patient selection (e.g., based on AAK grade) and/or 
use of molecules with specific nerve regenerative capacity may be of 
benefit in AAK. The recently approved recombinant human nerve 
growth factor (NGF) treatment (Cenegermin) may be of interest in this 
regard. Indicated for treatment of moderate to severe neurotrophic 
keratopathy (a rare disease characterized by diminished corneal inner-
vation, non-healing epithelial wounds and corneal ulceration), NGF 
stimulates corneal epithelial cell growth and survival, aids in the 
maintenance of limbal stem cell function, promotes tear production and 
supports corneal re-innervation [297]. In clinical studies, 65–75% of 
patients receiving an 8-week course of Cenegermin eye drops exhibited 
complete corneal healing, although relapse occurred in about 20% while 
eye pain and reduced visual acuity were frequently reported adverse 
effects [297,298]. Notably, it has also been shown that corneal subbasal 
nerve density significantly increased following an 8-week course of 
Cenegermin [299]. Whether these promising effects could be extended 
to AAK is unknown and would need to be explored; however, use of 
Cenegermin for conditions other than neurotrophic keratopathy is 
currently off-label. Here, animal models would be useful for initial 
investigations. 
4. Molecular biology and genetics perspective 
Due to the many observed PAX6 mutations independently leading to 
aniridia and the heterogeneous clinical phenotype, it is difficult to 
associate specific mutations to AAK severity [4]. However, some classes 
of mutations (selected missense or non-coding mutations) are associated 
with reduced AAK progression and mild or absent LSCD [29]. 
Comparative OMICs of such patient samples could help elucidate cor-
relations between specific mutations and degree of AAK severity at the 
molecular level [125,300]. Nonsense mediated decay (NMD) of mutant 
mRNA is the most common mechanism of PAX6 protein deficiency, but 
there is no evidence this is modulated by the position of mutations in the 
transcript. The effect of missense mutation is difficult to predict but 
some in vitro studies described the effect of the mutation in different 
binding domains. It might not be useful to compare different missense 
mutations with each other since they could have different properties. 
For PAX6 run-on mutations (with a mutated stop codon), it is thought 
(but not yet demonstrated) that the mutated PAX6 protein is degraded or 
not produced. Mutations in regulatory domains of PAX6 (also found as 
3′-cis-regulatory region deletions) are interesting since PAX6 reduction 
could be less pronounced, and these mutations have been related to 
milder phenotypes [4,206,300]. In rare cases, genes other than PAX6 
can putatively cause aniridia [301–303]. Primary culture of patient cells 
(both epithelial and mesenchymal) should help to identify deregulated 
genes important for AAK development especially in cases of aniridia 
with mild AAK, to discriminate from PAX6-dependent expression 
changes that are not causative of AAK [125]. Recent comprehensive 
reviews summarize in detail the genetics of congenital aniridia [1,2, 
304]. Although the impact of PAX6 levels and splice variants on iris and 
ciliary body development have been systematically studied [155], we 
lack such detailed knowledge for LSCs and corneal epithelial cells. Also, 
PAX6 protein has been described to be located in the nucleus, cytosol or 
even in secreted form. It must be further evaluated how localization of 
PAX6 is controlled by post-translational modifications. PAX6 mRNA 
expression may be not as dramatically altered as at the protein level, and 
thus mRNA expression and translation of PAX6 need to be studied in 
detail in cells such as LSCs and differentiated epithelium. Interestingly, 
it has recently been shown that Pax6 expression is negatively regulated 
by the microRNAs miR-7 and miR-135, and that protection of this 
inhibitory mechanism was capable of restoring PAX6 protein levels in 
isolated pancreatic islets in an aniridia mouse model [305]. It remains to 
be determined whether a similar regulatory mechanism also occurs in 
LSCs. Nevertheless, these data, in addition to the putative target 
miR-204-5p discussed earlier, appear to suggest that RNA-based thera-
pies could represent a potential innovative therapeutic strategy for AAK. 
5. Conclusions for further research strategies 
Nearly all patients with aniridia suffer from AAK [4]. The onset of 
clinically apparent AAK differs between individuals even with the same 
mutations. Based on our present level of knowledge, it is not clear if AAK 
is caused by LSCD while it seems likely that some loss of LSC function 
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occurs, it is not necessary to invoke LSCD as the main cause of the 
phenotype seen in AAK eyes. Clinical microscopy findings suggest that a 
minimal degree of keratopathy is likely to exist in all cases of aniridia 
even before ocular surface changes become visible at the slit lamp. This 
‘minimal keratopathy’ includes reduced mechanical touch sensitivity, a 
deficit of corneal nerves, and increased inflammatory cell presence in 
the central cornea [4]. LSCD may in fact be a consequence of the early 
minimal keratopathy in subjects where the specific PAX6 mutation 
predisposes the cornea to a progressive AAK phenotype. The minimal 
keratopathy may in turn have a developmental origin. The chronic 
wound healing pathology of the corneal epithelium in AAK may over-
whelm the PAX6+/− limbal regenerative potential during normal life 
[153,154]. Essential knowledge, however, is still lacking concerning the 
critical factors needed to specify and maintain the limbal niche and how 
these relate to PAX6 expression both prenatally and postnatally; there-
fore, pathogenic mechanisms at the molecular level are still speculative. 
Early indications are that PAX6 regulation of and by other genes and 
factors is complex, and multiple signaling pathways, molecular and 
cellular mechanisms and feedback loops appear to be active, resulting in 
the observed AAK phenotypes. Deciphering some of the key pathways 
and mechanisms involved can provide insights that will be important for 
future and new therapies targeting AAK, keeping in mind that the 
complexity itself may provide multiple potential therapeutic targets. 
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[159] Brémond-Gignac D. Le glaucome dans l’aniridie. J Fr Ophtalmol 2007;30:196–9. 
[160] Brandt JD, Casuso LA, Budenz DL. Markedly increased central corneal thickness: 
an unrecognized finding in congenital aniridia. Am J Ophthalmol 2004;137: 
348–50. 
[161] Whitson JT, Liang C, Godfrey DG, Petroll WM, Cavanagh HD, Patel D, et al. 
Central corneal thickness in patients with congenital aniridia. Eye Contact Lens 
2005;31:221–4. 
[162] Kirwan C, O’Keefe M, Fitzsimon S. Central corneal thickness and corneal diameter 
in premature infants. Acta Ophthalmol Scand 2005;83:751–3. 
[163] Baulmann DC, Ohlmann A, Flügel-Koch C, Goswami S, Cvekl A, Tamm ER. Pax6 
heterozygous eyes show defects in chamber angle differentiation that are 
associated with a wide spectrum of other anterior eye segment abnormalities. 
Mech Dev 2002;118:3–17. 
[164] Collinson JM, Quinn JC, Hill RE, West JD. The roles of Pax6 in the cornea, retina, 
and olfactory epithelium of the developing mouse embryo. Dev Biol 2003;255: 
303–12. 
[165] Funderburgh ML, Du Y, Mann MM, SundarRaj N, Funderburgh JL. PAX6 
expression identifies progenitor cells for corneal keratocytes. Faseb J 2005;19: 
1371–3. 
[166] Cvekl A, Tamm ER. Anterior eye development and ocular mesenchyme: new 
insights from mouse models and human diseases. Bioessays : news and reviews in 
molecular, cellular and developmental biology 2004;26:374–86. 
[167] Kamachi Y, Uchikawa M, Tanouchi A, Sekido R, Kondoh H. Pax6 and SOX2 form a 
co-DNA-binding partner complex that regulates initiation of lens development. 
Genes Dev 2001;15:1272–86. 
[168] Cooper ST, Hanson IM. A screen for proteins that interact with PAX6: C-terminal 
mutations disrupt interaction with HOMER3, DNCL1 and TRIM11. BMC Genet 
2005;6:43. 
[169] Chauhan BK, Reed NA, Zhang W, Duncan MK, Kilimann MW, Cvekl A. 
Identification of genes downstream of Pax6 in the mouse lens using cDNA 
microarrays. J Biol Chem 2002;277:11539–48. 
[170] Matsuo T, Osumi-Yamashita N, Noji S, Ohuchi H, Koyama E, Myokai F, et al. 
A mutation in the Pax-6 gene in rat small eye is associated with impaired 
migration of midbrain crest cells. Nat Genet 1993;3:299–304. 
[171] Aragona P, Rolando M. Towards a dynamic customised therapy for ocular surface 
dysfunctions. Br J Ophthalmol 2013;97:955. 
L. Latta et al.                                                                                                                                                                                                                                    
The Ocular Surface 22 (2021) 245–266
264
[172] Hogan BLM, Horsburgh G, Cohen J, Hetherington CM, Fisher G, Lyon MF. 
em>Small eyes</em> (<em>Sey</em>): a homozygous lethal mutation on 
chromosome 2 which affects the differentiation of both lens and nasal placodes in 
the mouse. J Embryol Exp Morphol 1986;97:95–110. 
[173] Makarenkova HP, Ito M, Govindarajan V, Faber SC, Sun L, McMahon G, et al. 
FGF10 is an inducer and Pax6 a competence factor for lacrimal gland 
development. Development 2000;127:2563–72. 
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